<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosgen</journal-id>
<journal-title-group>
<journal-title>PLoS Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7390</issn>
<issn pub-type="epub">1553-7404</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27832070</article-id>
<article-id pub-id-type="pmc">5104356</article-id>
<article-id pub-id-type="doi">10.1371/journal.pgen.1006314</article-id>
<article-id pub-id-type="publisher-id">PGENETICS-D-16-01220</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Endocrinology</subject>
<subj-group>
<subject>Endocrine Disorders</subject>
<subj-group>
<subject>Diabetes Mellitus</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Metabolic Disorders</subject>
<subj-group>
<subject>Diabetes Mellitus</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Cardiology</subject>
<subj-group>
<subject>Heart Failure</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Vascular Medicine</subject>
<subj-group>
<subject>Coronary Heart Disease</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Cardiology</subject>
<subj-group>
<subject>Coronary Heart Disease</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genetics of Disease</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Dementia</subject>
<subj-group>
<subject>Alzheimer Disease</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Dementia</subject>
<subj-group>
<subject>Alzheimer Disease</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Neurodegenerative Diseases</subject>
<subj-group>
<subject>Alzheimer Disease</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Cerebrovascular Diseases</subject>
<subj-group>
<subject>Stroke</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Vascular Medicine</subject>
<subj-group>
<subject>Stroke</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Mathematical and Statistical Techniques</subject>
<subj-group>
<subject>Statistical Methods</subject>
<subj-group>
<subject>Meta-Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Physical Sciences</subject>
<subj-group>
<subject>Mathematics</subject>
<subj-group>
<subject>Statistics (Mathematics)</subject>
<subj-group>
<subject>Statistical Methods</subject>
<subj-group>
<subject>Meta-Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
<subj-group>
<subject>Biomarkers</subject>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality</article-title>
<alt-title alt-title-type="running-head">Pleiotropic Genetic Effects on Diseases and Mortality</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kulminski</surname>
<given-names>Alexander M.</given-names>
</name>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Liang</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Culminskaya</surname>
<given-names>Irina</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6730-7320</contrib-id>
<name>
<surname>Loika</surname>
<given-names>Yury</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3980-225X</contrib-id>
<name>
<surname>Kernogitski</surname>
<given-names>Yelena</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4195-7832</contrib-id>
<name>
<surname>Arbeev</surname>
<given-names>Konstantin G.</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loiko</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arbeeva</surname>
<given-names>Liubov</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bagley</surname>
<given-names>Olivia</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6067-3192</contrib-id>
<name>
<surname>Duan</surname>
<given-names>Matt</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yashkin</surname>
<given-names>Arseniy</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fang</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9660-4316</contrib-id>
<name>
<surname>Kovtun</surname>
<given-names>Mikhail</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ukraintseva</surname>
<given-names>Svetlana V.</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Deqing</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yashin</surname>
<given-names>Anatoliy I.</given-names>
</name>
<xref ref-type="aff" rid="aff001"></xref>
</contrib>
</contrib-group>
<aff id="aff001">
<addr-line>Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC United States of America</addr-line>
</aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Barsh</surname>
<given-names>Gregory S.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>Stanford University School of Medicine, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p>
<list list-type="simple">
<list-item>
<p><bold>Conceptualization:</bold> AMK.</p>
</list-item>
<list-item>
<p><bold>Data curation:</bold> YL IC YK KGA LA OB MD AY FF MK SVU DW.</p>
</list-item>
<list-item>
<p><bold>Formal analysis:</bold> LH YL YK.</p>
</list-item>
<list-item>
<p><bold>Funding acquisition:</bold> AMK AIY KGA SVU.</p>
</list-item>
<list-item>
<p><bold>Investigation:</bold> AMK IC EL LH YL YK SVU.</p>
</list-item>
<list-item>
<p><bold>Methodology:</bold> AMK LH YL YK.</p>
</list-item>
<list-item>
<p><bold>Project administration:</bold> AMK.</p>
</list-item>
<list-item>
<p><bold>Resources:</bold> YL IC YK KGA LA OB MD AY FF MK DW.</p>
</list-item>
<list-item>
<p><bold>Supervision:</bold> AMK.</p>
</list-item>
<list-item>
<p><bold>Validation:</bold> AMK LH YL YK.</p>
</list-item>
<list-item>
<p><bold>Visualization:</bold> AMK LH YL YK.</p>
</list-item>
<list-item>
<p><bold>Writing – original draft:</bold> AMK.</p>
</list-item>
<list-item>
<p><bold>Writing – review &amp; editing:</bold> AMK AIY.</p>
</list-item>
</list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email>Alexander.Kulminski@duke.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2016</year>
</pub-date>
<volume>12</volume>
<issue>11</issue>
<elocation-id>e1006314</elocation-id>
<history>
<date date-type="received">
<day>1</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>8</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 Kulminski et al</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Kulminski et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pgen.1006314.pdf"></self-uri>
<related-article ext-link-type="doi" id="d35e452" related-article-type="companion" xlink:href="10.1371/journal.pgen.1006399">
<article-title>Suggestions from Geroscience for the genetics of age-related diseases</article-title>
</related-article>
<abstract>
<p>Gaining insights into genetic predisposition to age-related diseases and lifespan is a challenging task complicated by the elusive role of evolution in these phenotypes. To gain more insights, we combined methods of genome-wide and candidate-gene studies. Genome-wide scan in the Atherosclerosis Risk in Communities (ARIC) Study (N = 9,573) was used to pre-select promising loci. Candidate-gene methods were used to comprehensively analyze associations of novel uncommon variants in Caucasians (minor allele frequency~2.5%) located in band 2q22.3 with risks of coronary heart disease (CHD), heart failure (HF), stroke, diabetes, cancer, neurodegenerative diseases (ND), and mortality in the ARIC study, the Framingham Heart Study (N = 4,434), and the Health and Retirement Study (N = 9,676). We leveraged the analyses of pleiotropy, age-related heterogeneity, and causal inferences. Meta-analysis of the results from these comprehensive analyses shows that the minor allele increases risks of death by about 50% (<italic>p</italic> = 4.6×10<sup>−9</sup>), CHD by 35% (<italic>p</italic> = 8.9×10<sup>−6</sup>), HF by 55% (<italic>p</italic> = 9.7×10<sup>−5</sup>), stroke by 25% (<italic>p</italic> = 4.0×10<sup>−2</sup>), and ND by 100% (<italic>p</italic> = 1.3×10<sup>−3</sup>). This allele also significantly influences each of two diseases, diabetes and cancer, in antagonistic fashion in different populations. Combined significance of the pleiotropic effects was <italic>p</italic> = 6.6×10<sup>−21</sup>. Causal mediation analyses show that endophenotypes explained only small fractions of these effects. This locus harbors an evolutionary conserved gene-desert region with non-coding intergenic sequences likely involved in regulation of protein-coding flanking genes <italic>ZEB2</italic> and <italic>ACVR2A</italic>. This region is intensively studied for mutations causing severe developmental/genetic disorders. Our analyses indicate a promising target region for interventions aimed to reduce risks of many major human diseases and mortality.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>Biomedical research and medical care are traditionally focused on individual health conditions in order to postpone, ameliorate, or prevent the accumulation of morbidities in late life. An attractive idea is to find factors, which could reduce burden of not just one disease but a major subset of them to efficiently extend healthy lifespan. Here we focus on the analyses of genetic predisposition to risks of major human age-related diseases and mortality. The analyses highlight a locus in band 2q22.3 associated with risks of coronary heart disease, heart failure, stroke, diabetes, cancer, neurodegenerative diseases, and death. Our analyses indicate a promising target region for interventions aimed to reduce risks of many major human diseases and mortality.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
<institution>National Institute on Aging</institution>
</institution-wrap>
</funding-source>
<award-id>P01 AG043352</award-id>
<principal-award-recipient>
<name>
<surname>Kulminski</surname>
<given-names>Alexander M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
<institution>National Institute on Aging</institution>
</institution-wrap>
</funding-source>
<award-id>R01AG047310</award-id>
<principal-award-recipient>
<name>
<surname>Kulminski</surname>
<given-names>Alexander M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
<institution>National Institute on Aging</institution>
</institution-wrap>
</funding-source>
<award-id>P01 AG043352</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4195-7832</contrib-id>
<name>
<surname>Arbeev</surname>
<given-names>Konstantin G.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
<institution>National Institute on Aging</institution>
</institution-wrap>
</funding-source>
<award-id>P01 AG043352</award-id>
<principal-award-recipient>
<name>
<surname>Ukraintseva</surname>
<given-names>Svetlana V.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000049</institution-id>
<institution>National Institute on Aging</institution>
</institution-wrap>
</funding-source>
<award-id>P01 AG043352</award-id>
<principal-award-recipient>
<name>
<surname>Yashin</surname>
<given-names>Anatoliy I.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>The research reported in this paper was supported by Grants No P01 AG043352 and R01AG047310 from the National Institute on Aging (NIA), <ext-link ext-link-type="uri" xlink:href="https://www.nia.nih.gov">https://www.nia.nih.gov</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH).</funding-statement>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="7"></table-count>
<page-count count="20"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>This manuscript was prepared using controlled-access data obtained though dbGaP (accession numbers phs000007.v22.p8, phs000280.v2.p1, phs000428.v1.p1). Phenotypic HRS data are available publicly and through restricted access from <ext-link ext-link-type="uri" xlink:href="http://hrsonline.isr.umich.edu/index.php?p=data">http://hrsonline.isr.umich.edu/index.php?p=data</ext-link>.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>This manuscript was prepared using controlled-access data obtained though dbGaP (accession numbers phs000007.v22.p8, phs000280.v2.p1, phs000428.v1.p1). Phenotypic HRS data are available publicly and through restricted access from <ext-link ext-link-type="uri" xlink:href="http://hrsonline.isr.umich.edu/index.php?p=data">http://hrsonline.isr.umich.edu/index.php?p=data</ext-link>.</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The demographic transition on aging of populations in developed countries requires strategies, which could extend healthspan and lifespan, and compress morbidity [<xref ref-type="bibr" rid="pgen.1006314.ref001">1</xref>–<xref ref-type="bibr" rid="pgen.1006314.ref003">3</xref>]. Breakthroughs in genome-wide sequencing and high-throughput genotyping raised enthusiasm for advancing the progress in the field by discovering genes influencing various health-related traits. To accelerate the progress, one necessarily faces the need to deal with genetic predisposition to complex, inherently heterogeneous, age-related traits, i.e., traits that are characteristic of the elderly people in modern societies.</p>
<p>Heterogeneity is the result of various processes. Of the most familiar sources of heterogeneity, genome-wide association studies (GWAS) commonly handle those associated with evolutionarily selected genetic patterns in populations [<xref ref-type="bibr" rid="pgen.1006314.ref004">4</xref>] and complex etiologies of human health-related phenotypes [<xref ref-type="bibr" rid="pgen.1006314.ref005">5</xref>].</p>
<p>Age-related traits are a special case of heterogeneous phenotypes, because they emerge as a new <italic>widespread</italic> phenomenon in humans [<xref ref-type="bibr" rid="pgen.1006314.ref006">6</xref>], especially given substantially shorter lifespan of our even recent predecessors [<xref ref-type="bibr" rid="pgen.1006314.ref007">7</xref>], and because they are characteristic of the post-reproductive period, when the role of evolutionary selection in these traits is elusive [<xref ref-type="bibr" rid="pgen.1006314.ref006">6</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref008">8</xref>–<xref ref-type="bibr" rid="pgen.1006314.ref012">12</xref>]. These factors imply that “diseases are not shaped by selection,” [<xref ref-type="bibr" rid="pgen.1006314.ref006">6</xref>], i.e., evolution did not fix the molecular basis of age-related traits. The latter makes the analyses of genetic influence on such traits be a more challenging task than that of fitness-related traits (e.g. height [<xref ref-type="bibr" rid="pgen.1006314.ref013">13</xref>]). An important challenge is a special type of heterogeneity attributed to the elusive role of evolution in shaping the genetic basis of age-related traits. This heterogeneity is the result of age-related processes in an organism and compositional changes in a population in changing environment [<xref ref-type="bibr" rid="pgen.1006314.ref009">9</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref014">14</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref015">15</xref>].</p>
<p>The age-related heterogeneity implies the potential existence of gene-endophenotype-phenotype pathways (i.e., mechanisms mediating the effects between genes and age-related traits) and that these mechanisms can change with age, time, and population composition even if the same genetic variant and trait are considered. This heterogeneity can naturally contribute to non-replication of genetic effects in different populations even in case of populations of the same ancestry and phenotypes [<xref ref-type="bibr" rid="pgen.1006314.ref016">16</xref>–<xref ref-type="bibr" rid="pgen.1006314.ref018">18</xref>].</p>
<p>The elusive role of evolution in fixing molecular basis of age-related traits can also benefit genetic analyses because it can enhance the basis of pleiotropic influences on different traits, including “apparently distinct” ones [<xref ref-type="bibr" rid="pgen.1006314.ref019">19</xref>]. Statistical benefit is that pleiotropic analysis may improve power [<xref ref-type="bibr" rid="pgen.1006314.ref020">20</xref>]. Substantive benefit is that pleiotropic influences on apparently distinct traits are a part of an attractive gerontological idea which has been conceptualized as geroscience [<xref ref-type="bibr" rid="pgen.1006314.ref021">21</xref>]. This concept assumes that age [<xref ref-type="bibr" rid="pgen.1006314.ref022">22</xref>] and aging [<xref ref-type="bibr" rid="pgen.1006314.ref023">23</xref>] can be major risk factors of geriatric diseases of distinct etiologies [<xref ref-type="bibr" rid="pgen.1006314.ref024">24</xref>]. Detecting such pleiotropy and developing gene-based interventions may strengthen strategies for reducing burden of not just one disease but a major subset of them to efficiently extend healthspan and lifespan [<xref ref-type="bibr" rid="pgen.1006314.ref023">23</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref025">25</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref026">26</xref>].</p>
<p>Given specific properties of age-related traits, common methods of GWAS of these traits may be insufficient and more comprehensive methods typical for candidate gene studies may be needed. One strategy to improve genetic analyses of age-related traits is to use genome-wide scan for pre-selection of promising SNPs and more comprehensive methods for detail analyses of these SNPs in large samples.</p>
<p>Following this approach, we selected promising SNPs from GWAS of the Atherosclerosis Risk in Communities (ARIC) Study (see <xref ref-type="sec" rid="sec014">Methods</xref>). Then we conducted detail analysis of associations of SNPs at a promising locus in band 2q22.3 with risks of major diseases including coronary heart disease (CHD), heart failure (HF), stroke, diabetes, cancer, and neurodegenerative diseases (ND, dementias including Alzheimer’s type) and risks of death using the ARIC, the Framingham Heart Study (FHS), and the Health and Retirement Study (HRS). We leveraged the analyses of pleiotropy, age-related heterogeneity, and causal inferences. In causal mediation analyses, we used biomarkers (body mass index [BMI], total [TC] and high-density lipoprotein [HDL-C] cholesterols; triglycerides [TG], systolic [SBP] and diastolic [DBP] blood pressures) as endophenotypes for diseases or death and diseases as endophenotypes for death. We show that the minor allele increases risks of death by about 50% (<italic>p</italic> = 4.6×10<sup>−9</sup>), CHD by 35% (<italic>p</italic> = 8.9×10<sup>−6</sup>), HF by 55% (<italic>p</italic> = 9.7×10<sup>−5</sup>), stroke by 25% (<italic>p</italic> = 4.0×10<sup>−2</sup>), and ND by 100% (<italic>p</italic> = 1.3×10<sup>−3</sup>). This allele also significantly influences each of two diseases, diabetes and cancer, in antagonistic fashion in different populations. Combined significance of the pleiotropic effects was <italic>p</italic> = 6.6×10<sup>−21</sup>.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<p>Basic characteristics of the ARIC, FHS, and HRS genotyped participants relevant to our analyses and the available sample sizes for carriers and non-carriers of the minor allele (rs222826_T in ARIC and FHS and rs222827_A in HRS) are given in <xref ref-type="table" rid="pgen.1006314.t001">Table 1</xref> (see <xref ref-type="sec" rid="sec014">Methods</xref>).</p>
<table-wrap id="pgen.1006314.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t001</object-id>
<label>Table 1</label>
<caption>
<title>Basic characteristics of carriers and non-carriers of the minor allele of rs222826 or rs222827 SNPs in the selected studies.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t001g" xlink:href="pgen.1006314.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" colspan="1" rowspan="1">Factors</th>
<th align="left" colspan="2" rowspan="1">ARIC, rs222826</th>
<th align="left" colspan="2" rowspan="1">FHS_C1, rs222826</th>
<th align="left" colspan="2" rowspan="1">FHSO, rs222826</th>
<th align="left" colspan="2" rowspan="1">HRS, rs222827</th>
</tr>
<tr>
<th align="justify" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">CC</th>
<th align="left" colspan="1" rowspan="1">CT+TT</th>
<th align="left" colspan="1" rowspan="1">CC</th>
<th align="left" colspan="1" rowspan="1">CT+TT</th>
<th align="left" colspan="1" rowspan="1">CC</th>
<th align="left" colspan="1" rowspan="1">CT+TT</th>
<th align="left" colspan="1" rowspan="1">GG</th>
<th align="left" colspan="1" rowspan="1">GA+AA</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" colspan="1" rowspan="1">N (%<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">9154 (95.6)</td>
<td align="left" colspan="1" rowspan="1">419 (4.4)</td>
<td align="left" colspan="1" rowspan="1">982 (94.7)</td>
<td align="left" colspan="1" rowspan="1">55 (5.3)</td>
<td align="left" colspan="1" rowspan="1">3184 (93.7)</td>
<td align="left" colspan="1" rowspan="1">213 (6.3)</td>
<td align="left" colspan="1" rowspan="1">9308 (96.2)</td>
<td align="left" colspan="1" rowspan="1">368 (3.8)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Age, mean (SD), years</td>
<td align="left" colspan="1" rowspan="1">54.3 (5.7)</td>
<td align="left" colspan="1" rowspan="1">54.6 (5.6)</td>
<td align="left" colspan="1" rowspan="1">37.9 (6)</td>
<td align="left" colspan="1" rowspan="1">37.3 (5.9)</td>
<td align="left" colspan="1" rowspan="1">35.4 (10)</td>
<td align="left" colspan="1" rowspan="1">35.1 (9.7)</td>
<td align="left" colspan="1" rowspan="1">58.1 (9.1)</td>
<td align="left" colspan="1" rowspan="1">58 (9)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">LS, mean (SD), years</td>
<td align="left" colspan="1" rowspan="1">69.8 (5.9)</td>
<td align="left" colspan="1" rowspan="1">69.8 (5.8)</td>
<td align="left" colspan="1" rowspan="1">88.2 (7.1)</td>
<td align="left" colspan="1" rowspan="1">87.7 (6.5)</td>
<td align="left" colspan="1" rowspan="1">72.1 (9.2)</td>
<td align="left" colspan="1" rowspan="1">70.9 (9.1)</td>
<td align="left" colspan="1" rowspan="1">75 (10.2)</td>
<td align="left" colspan="1" rowspan="1">74.7 (10.1)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">BC, mean (SD), years</td>
<td align="left" colspan="1" rowspan="1">1933.3 (5.8)</td>
<td align="left" colspan="1" rowspan="1">1933.1 (5.7)</td>
<td align="left" colspan="1" rowspan="1">1909.7 (6.1)</td>
<td align="left" colspan="1" rowspan="1">1910.1 (5.7)</td>
<td align="left" colspan="1" rowspan="1">1935.1 (9.9)</td>
<td align="left" colspan="1" rowspan="1">1935.5 (9.4)</td>
<td align="left" colspan="1" rowspan="1">1940.2 (10.3)</td>
<td align="left" colspan="1" rowspan="1">1938.5 (10.3)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">BMI, mean (SD), kg/m<sup>2</sup></td>
<td align="left" colspan="1" rowspan="1">27 (4.8)</td>
<td align="left" colspan="1" rowspan="1">27.4 (5.1)</td>
<td align="left" colspan="1" rowspan="1">24.7 (3.7)</td>
<td align="left" colspan="1" rowspan="1">23.5 (3.2)</td>
<td align="left" colspan="1" rowspan="1">25.2 (4.3)</td>
<td align="left" colspan="1" rowspan="1">25.7 (4.3)</td>
<td align="left" colspan="1" rowspan="1">26.9 (5)</td>
<td align="left" colspan="1" rowspan="1">27 (5.2)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">TC<xref ref-type="table-fn" rid="t001fn009"><sup>c</sup></xref>, mean (SD), mg/dl</td>
<td align="left" colspan="1" rowspan="1">214.9 (40.8)</td>
<td align="left" colspan="1" rowspan="1">217 (40.3)</td>
<td align="left" colspan="1" rowspan="1">238.3 (44.2)</td>
<td align="left" colspan="1" rowspan="1">239.3 (42.4)</td>
<td align="left" colspan="1" rowspan="1">194.3 (38)</td>
<td align="left" colspan="1" rowspan="1">194.5 (39)</td>
<td align="left" colspan="1" rowspan="1">194.6 (44.3)</td>
<td align="left" colspan="1" rowspan="1">192.1 (44.2)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">HDL-C<xref ref-type="table-fn" rid="t001fn009"><sup>c</sup></xref>, mean (SD), mg/dl</td>
<td align="left" colspan="1" rowspan="1">50.6 (16.7)</td>
<td align="left" colspan="1" rowspan="1">48.6 (16.1)</td>
<td align="left" colspan="1" rowspan="1">49.6 (14.5)</td>
<td align="left" colspan="1" rowspan="1">49.4 (16.1)</td>
<td align="left" colspan="1" rowspan="1">50.9 (14.6)</td>
<td align="left" colspan="1" rowspan="1">50.1 (14.6)</td>
<td align="left" colspan="1" rowspan="1">56.1 (15.7)</td>
<td align="left" colspan="1" rowspan="1">55 (16.4)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">TG<xref ref-type="table-fn" rid="t001fn009"><sup>c</sup></xref>, mean (SD), mg/dl</td>
<td align="left" colspan="1" rowspan="1">136.9 (91.4)</td>
<td align="left" colspan="1" rowspan="1">149.4 (104.9)</td>
<td align="left" colspan="1" rowspan="1">151.2 (99.9)</td>
<td align="left" colspan="1" rowspan="1">151 (86.8)</td>
<td align="left" colspan="1" rowspan="1">91.9 (85.5)</td>
<td align="left" colspan="1" rowspan="1">92.9 (71.1)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">SBP, mean (SD), mmHg</td>
<td align="left" colspan="1" rowspan="1">139 (15.5)</td>
<td align="left" colspan="1" rowspan="1">139.2 (16.7)</td>
<td align="left" colspan="1" rowspan="1">126.2 (15.1)</td>
<td align="left" colspan="1" rowspan="1">123 (11.2)</td>
<td align="left" colspan="1" rowspan="1">120.2 (14.5)</td>
<td align="left" colspan="1" rowspan="1">121.3 (14.7)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">DBP, mean (SD), mmHg</td>
<td align="left" colspan="1" rowspan="1">92 (9.8)</td>
<td align="left" colspan="1" rowspan="1">92.2 (9.4)</td>
<td align="left" colspan="1" rowspan="1">79.5 (9.6)</td>
<td align="left" colspan="1" rowspan="1">78.7 (8.1)</td>
<td align="left" colspan="1" rowspan="1">77.7 (10)</td>
<td align="left" colspan="1" rowspan="1">78.3 (10.3)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">CHD, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">846 (9.2)</td>
<td align="left" colspan="1" rowspan="1">62 (14.8)</td>
<td align="left" colspan="1" rowspan="1">385 (39.2)</td>
<td align="left" colspan="1" rowspan="1">23 (41.8)</td>
<td align="left" colspan="1" rowspan="1">557 (17.5)</td>
<td align="left" colspan="1" rowspan="1">36 (16.9)</td>
<td align="left" colspan="1" rowspan="1">3579 (38.5)</td>
<td align="left" colspan="1" rowspan="1">149 (40.5)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">HF, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">766 (8.9)</td>
<td align="left" colspan="1" rowspan="1">49 (12.6)</td>
<td align="left" colspan="1" rowspan="1">272 (27.7)</td>
<td align="left" colspan="1" rowspan="1">18 (32.7)</td>
<td align="left" colspan="1" rowspan="1">237 (7.4)</td>
<td align="left" colspan="1" rowspan="1">21 (9.9)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Stroke, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">507 (5.5)</td>
<td align="left" colspan="1" rowspan="1">28 (6.7)</td>
<td align="left" colspan="1" rowspan="1">191 (19.5)</td>
<td align="left" colspan="1" rowspan="1">16 (29.1)</td>
<td align="left" colspan="1" rowspan="1">191 (6)</td>
<td align="left" colspan="1" rowspan="1">17 (8)</td>
<td align="left" colspan="1" rowspan="1">1184 (12.7)</td>
<td align="left" colspan="1" rowspan="1">46 (12.5)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Diabetes, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">1608 (18)</td>
<td align="left" colspan="1" rowspan="1">94 (22.9)</td>
<td align="left" colspan="1" rowspan="1">305 (31.1)</td>
<td align="left" colspan="1" rowspan="1">13 (23.6)</td>
<td align="left" colspan="1" rowspan="1">312 (9.9)</td>
<td align="left" colspan="1" rowspan="1">29 (13.7)</td>
<td align="left" colspan="1" rowspan="1">2375 (25.5)</td>
<td align="left" colspan="1" rowspan="1">116 (31.5)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Cancer, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">1225 (13.4)</td>
<td align="left" colspan="1" rowspan="1">66 (15.8)</td>
<td align="left" colspan="1" rowspan="1">467 (47.6)</td>
<td align="left" colspan="1" rowspan="1">28 (50.9)</td>
<td align="left" colspan="1" rowspan="1">1117 (35.1)</td>
<td align="left" colspan="1" rowspan="1">81 (38)</td>
<td align="left" colspan="1" rowspan="1">2213 (23.8)</td>
<td align="left" colspan="1" rowspan="1">71 (19.3)</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">ND, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">266 (27.7)</td>
<td align="left" colspan="1" rowspan="1">24 (43.6)</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Death, yes (%<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1">1344 (14.7)</td>
<td align="left" colspan="1" rowspan="1">79 (18.9)</td>
<td align="left" colspan="1" rowspan="1">880 (89.6)</td>
<td align="left" colspan="1" rowspan="1">54 (98.2)</td>
<td align="left" colspan="1" rowspan="1">656 (20.6)</td>
<td align="left" colspan="1" rowspan="1">60 (28.2)</td>
<td align="left" colspan="1" rowspan="1">1230 (13.2)</td>
<td align="left" colspan="1" rowspan="1">59 (16)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p>HRS SNP used is proxy SNP rs222827, which is in perfect linkage disequilibrium (LD), <italic>r</italic><sup><italic>2</italic></sup> = 1, with rs222826 in CEU population; these SNPs are 90 bp apart.</p>
</fn>
<fn id="t001fn002">
<p>Percentage is within</p>
</fn>
<fn id="t001fn003">
<p><sup>a</sup> the genotyped sample</p>
</fn>
<fn id="t001fn004">
<p><sup>b</sup> each genotype.</p>
</fn>
<fn id="t001fn005">
<p>N denotes sample size; NA = not available.</p>
</fn>
<fn id="t001fn006">
<p>Mean age is given at baselines; LS denotes lifespan measured by age at death or the end of follow-up; BC denotes birth cohorts.</p>
</fn>
<fn id="t001fn007">
<p>ARIC = the Atherosclerosis Risk in Communities Study, FHS_C1 = the Framingham Heart Study (FHS) original cohort; FHSO = the FHS Offspring cohort, and HRS = the Health and Retirement Study.</p>
</fn>
<fn id="t001fn008">
<p>BMI = body mass index; TC = total cholesterol; HDL-C = high-density lipoprotein cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood pressure; CHD = coronary heart disease; HF = heart failure; and ND = neurodegenerative diseases (dementias including Alzheimer’s type).</p>
</fn>
<fn id="t001fn009">
<p><sup>c</sup> Means of TC, HDL-C, and TG concentrations are given at 9<sup>th</sup> FHS_C1 examination because this visit included the largest sample size with non-missing information on these lipids. For FHSO and other studies means of lipid concentrations were representatively given at baselines.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="sec003">
<title>Risks of diseases and death</title>
<p><xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref> shows the estimates of risks of major human diseases or death for carriers and non-carriers of the minor allele. This allele is highly significantly associated with risks of CHD in ARIC (HR = 1.74, <italic>p</italic> = 1.1×10<sup>−7</sup>) and death in FHS (HR = 1.64, <italic>p</italic> = 1.3×10<sup>−6</sup>). Leveraging these pleiotropic associations, the global null hypothesis that neither of these associations is true evaluated using the Fisher’s combined probability test [<xref ref-type="bibr" rid="pgen.1006314.ref027">27</xref>] is <italic>p</italic> = 4.7×10<sup>−12</sup>. This result implies that the probability of being a false finding in this case is much smaller than that defined by the genome wide significance (<italic>p</italic><sub><italic>GW</italic></sub> = 5×10<sup>−8</sup>). Multiple testing correction for 15 tests with other phenotypes, which are not included in the Fisher’s test (see <xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref>), does not alter this result, <italic>p</italic> = 4.7×10<sup>−12</sup> × 15 = 7.1×10<sup>−11</sup> &lt;&lt; <italic>p</italic><sub><italic>GW</italic></sub>.</p>
<table-wrap id="pgen.1006314.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t002</object-id>
<label>Table 2</label>
<caption>
<title>Hazard ratios for major human diseases and death for the rs222826 <xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref> minor allele carriers in ARIC, FHS, and HRS.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t002g" xlink:href="pgen.1006314.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="2">Outcome</th>
<th align="left" colspan="3" rowspan="1">ARIC, N = 9,618</th>
<th align="center" colspan="3" rowspan="1">FHS, N = 4,700</th>
<th align="center" colspan="3" rowspan="1">HRS<xref ref-type="table-fn" rid="t002fn001"><sup>a</sup></xref>, N = 9,735</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">HR</th>
<th align="left" colspan="1" rowspan="1">95% CI</th>
<th align="left" colspan="1" rowspan="1">p-value</th>
<th align="left" colspan="1" rowspan="1">HR</th>
<th align="left" colspan="1" rowspan="1">95% CI</th>
<th align="left" colspan="1" rowspan="1">p-value</th>
<th align="left" colspan="1" rowspan="1">HR<xref ref-type="table-fn" rid="t002fn006"><sup>b</sup></xref></th>
<th align="left" colspan="1" rowspan="1">95% CI</th>
<th align="left" colspan="1" rowspan="1">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="center" colspan="1" rowspan="1">1.74</td>
<td align="center" colspan="1" rowspan="1">1.42–2.14</td>
<td align="center" colspan="1" rowspan="1">1.1E-7</td>
<td align="center" colspan="1" rowspan="1">1.07</td>
<td align="center" colspan="1" rowspan="1">0.82–1.41</td>
<td align="center" colspan="1" rowspan="1">6.1E-1</td>
<td align="center" colspan="1" rowspan="1">1.10</td>
<td align="center" colspan="1" rowspan="1">0.88–1.38</td>
<td align="center" colspan="1" rowspan="1">3.8E-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HF</td>
<td align="center" colspan="1" rowspan="1">1.50</td>
<td align="center" colspan="1" rowspan="1">1.12–2.01</td>
<td align="center" colspan="1" rowspan="1">6.1E-3</td>
<td align="center" colspan="1" rowspan="1">1.52</td>
<td align="center" colspan="1" rowspan="1">1.09–2.12</td>
<td align="center" colspan="1" rowspan="1">1.5E-2</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stroke</td>
<td align="center" colspan="1" rowspan="1">1.18</td>
<td align="center" colspan="1" rowspan="1">0.75–1.85</td>
<td align="center" colspan="1" rowspan="1">4.7E-1</td>
<td align="center" colspan="1" rowspan="1">1.70</td>
<td align="center" colspan="1" rowspan="1">1.19–2.43</td>
<td align="center" colspan="1" rowspan="1">3.6E-3</td>
<td align="center" colspan="1" rowspan="1">1.01</td>
<td align="center" colspan="1" rowspan="1">0.72–1.38</td>
<td align="center" colspan="1" rowspan="1">9.9E-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diabetes</td>
<td align="center" colspan="1" rowspan="1">1.35</td>
<td align="center" colspan="1" rowspan="1">1.01–1.81</td>
<td align="center" colspan="1" rowspan="1">4.2E-2</td>
<td align="center" colspan="1" rowspan="1">1.05</td>
<td align="center" colspan="1" rowspan="1">0.75–1.48</td>
<td align="center" colspan="1" rowspan="1">7.6E-1</td>
<td align="center" colspan="1" rowspan="1">1.35</td>
<td align="center" colspan="1" rowspan="1">1.07–1.69</td>
<td align="center" colspan="1" rowspan="1">9.9E-3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cancer</td>
<td align="center" colspan="1" rowspan="1">1.22</td>
<td align="center" colspan="1" rowspan="1">0.89–1.68</td>
<td align="center" colspan="1" rowspan="1">2.2E-1</td>
<td align="center" colspan="1" rowspan="1">1.24</td>
<td align="center" colspan="1" rowspan="1">1.02–1.50</td>
<td align="center" colspan="1" rowspan="1">3.4E-2</td>
<td align="center" colspan="1" rowspan="1">0.76</td>
<td align="center" colspan="1" rowspan="1">0.59–1.00</td>
<td align="center" colspan="1" rowspan="1">4.8E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Death</td>
<td align="center" colspan="1" rowspan="1">1.32</td>
<td align="center" colspan="1" rowspan="1">1.05–1.65</td>
<td align="center" colspan="1" rowspan="1">1.7E-2</td>
<td align="center" colspan="1" rowspan="1">1.64</td>
<td align="center" colspan="1" rowspan="1">1.34–2.00</td>
<td align="center" colspan="1" rowspan="1">1.3E-6</td>
<td align="center" colspan="1" rowspan="1">1.31</td>
<td align="center" colspan="1" rowspan="1">1.01–1.70</td>
<td align="center" colspan="1" rowspan="1">4.4E-2</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p><sup>a</sup> HRS SNP used is proxy SNP rs222827</p>
</fn>
<fn id="t002fn002">
<p>N denotes sample size; NA = not available or not estimated</p>
</fn>
<fn id="t002fn003">
<p>ARIC = the Atherosclerosis Risk in Communities Study, FHS = the Framingham Heart Study (FHS); and HRS = the Health and Retirement Study.</p>
</fn>
<fn id="t002fn004">
<p>CHD = coronary heart disease; HF = heart failure.</p>
</fn>
<fn id="t002fn005">
<p>HR denotes hazard ratio from the Cox proportional hazards regression model.</p>
</fn>
<fn id="t002fn006">
<p><sup>b</sup> In HRS HR was evaluated for risk of death. For diseases in HRS we evaluated odds ratios (OR) using logistic regression model because no information on onsets of these diseases was available.</p>
</fn>
<fn id="t002fn007">
<p>CI denotes confidence interval</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The minor allele is also nominally significantly (<italic>p</italic>&lt;5.0×10<sup>−2</sup>) associated with risks of death in two other studies (ARIC and HRS) and with risks of HF (ARIC, FHS), stroke (FHS), diabetes (ARIC, HRS), and cancer (FHS, HRS). It increases risks of all diseases and death (<xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref>), except cancer in HRS. All non-significant effects were also detrimental.</p>
</sec>
<sec id="sec004">
<title>Explicating age-related genetic heterogeneity in the FHS</title>
<p>FHS sample includes two cohorts of participants from different generations (the FHS original cohort and the FHS offspring [FHSO] cohorts) which may be a natural source of age-related genetic heterogeneity (see the <xref ref-type="sec" rid="sec001">Introduction</xref>).</p>
<p>Evaluation of risks of the selected diseases and death in each cohort separately (<xref ref-type="table" rid="pgen.1006314.t003">Table 3</xref>) shows that weak and highly non-significant association of the rs222826_T allele with risk of diabetes in the entire FHS sample (HR = 1.05, <italic>p</italic> = 7.6×10<sup>−1</sup>; <xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref>) is due to antagonistic effects of this allele on risks of diabetes in the FHS original (HR = 0.71, <italic>p</italic> = 2.3×10<sup>−1</sup>) and FHSO (HR = 1.36, <italic>p</italic> = 1.5×10<sup>−1</sup>) cohorts. Formal test shows that multiplicative interaction of the minor allele with these FHS cohorts is significant (HR = 2.5, <italic>p</italic> = 1.1×10<sup>−2</sup>). Explicating this heterogeneity, the effect size in the FHSO (HR = 1.36, <italic>p</italic> = 1.5×10<sup>−1</sup>) became the same as in ARIC (HR = 1.35, <italic>p</italic> = 4.2×10<sup>−2</sup>) and HRS (OR = 1.35, <italic>p</italic> = 9.9×10<sup>−3</sup>). Important result is that we observe the same effect sizes in three cohorts of younger individuals who were born in the same time period around 1930s-1940s (<xref ref-type="table" rid="pgen.1006314.t001">Table 1</xref>). The opposite effect is observed in the FHS original cohort for individuals from substantially older generation born around 1910s (<xref ref-type="table" rid="pgen.1006314.t001">Table 1</xref>).</p>
<table-wrap id="pgen.1006314.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t003</object-id>
<label>Table 3</label>
<caption>
<title>Hazard ratios for major human diseases and death for the rs222826_T (minor) allele carriers in the Framingham cohorts.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t003g" xlink:href="pgen.1006314.t003"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="2">Outcome</th>
<th align="center" colspan="3" rowspan="1">FHS_C1, N = 1,105</th>
<th align="center" colspan="3" rowspan="1">FHSO, N = 3,595</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">HR</th>
<th align="left" colspan="1" rowspan="1">95% CI</th>
<th align="left" colspan="1" rowspan="1">p-value</th>
<th align="left" colspan="1" rowspan="1">HR</th>
<th align="left" colspan="1" rowspan="1">95% CI</th>
<th align="left" colspan="1" rowspan="1">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">CHD</td>
<td align="center" colspan="1" rowspan="1">1.20</td>
<td align="center" colspan="1" rowspan="1">0.79–1.83</td>
<td align="center" colspan="1" rowspan="1">4.0E-1</td>
<td align="center" colspan="1" rowspan="1">0.99</td>
<td align="center" colspan="1" rowspan="1">0.70–1.41</td>
<td align="center" colspan="1" rowspan="1">9.7E-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CHD<sub>65+</sub></td>
<td align="center" colspan="1" rowspan="1">1.50</td>
<td align="center" colspan="1" rowspan="1">0.95–2.37</td>
<td align="center" colspan="1" rowspan="1">7.9E-2</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HF</td>
<td align="center" colspan="1" rowspan="1">1.41</td>
<td align="center" colspan="1" rowspan="1">0.87–2.28</td>
<td align="center" colspan="1" rowspan="1">1.6E-1</td>
<td align="center" colspan="1" rowspan="1">1.70</td>
<td align="center" colspan="1" rowspan="1">1.07–2.70</td>
<td align="center" colspan="1" rowspan="1">2.5E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stroke</td>
<td align="center" colspan="1" rowspan="1">1.91</td>
<td align="center" colspan="1" rowspan="1">1.10–3.31</td>
<td align="center" colspan="1" rowspan="1">2.1E-2</td>
<td align="center" colspan="1" rowspan="1">1.60</td>
<td align="center" colspan="1" rowspan="1">0.97–2.65</td>
<td align="center" colspan="1" rowspan="1">6.8E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diabetes</td>
<td align="center" colspan="1" rowspan="1">0.71</td>
<td align="center" colspan="1" rowspan="1">0.40–1.24</td>
<td align="center" colspan="1" rowspan="1">2.3E-1</td>
<td align="center" colspan="1" rowspan="1">1.36</td>
<td align="center" colspan="1" rowspan="1">0.90–2.06</td>
<td align="center" colspan="1" rowspan="1">1.5E-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cancer</td>
<td align="center" colspan="1" rowspan="1">1.21</td>
<td align="center" colspan="1" rowspan="1">0.82–1.77</td>
<td align="center" colspan="1" rowspan="1">3.4E-1</td>
<td align="center" colspan="1" rowspan="1">1.25</td>
<td align="center" colspan="1" rowspan="1">1.00–1.58</td>
<td align="center" colspan="1" rowspan="1">5.2E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="center" colspan="1" rowspan="1">1.89</td>
<td align="center" colspan="1" rowspan="1">1.24–2.88</td>
<td align="center" colspan="1" rowspan="1">2.9E-3</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Death</td>
<td align="center" colspan="1" rowspan="1">1.45</td>
<td align="center" colspan="1" rowspan="1">1.07–1.97</td>
<td align="center" colspan="1" rowspan="1">1.7E-2</td>
<td align="center" colspan="1" rowspan="1">1.90</td>
<td align="center" colspan="1" rowspan="1">1.44–2.50</td>
<td align="center" colspan="1" rowspan="1">4.7E-6</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p>N denotes sample size; NA = not available or not estimated</p>
</fn>
<fn id="t003fn002">
<p>FHS_C1 = the Framingham Heart Study (FHS) original cohort; FHSO = the FHS Offspring cohort.</p>
</fn>
<fn id="t003fn003">
<p>CHD = coronary heart disease; CHD<sub>65+</sub> = coronary heart disease with onset at 65 years and older; HF = heart failure; ND = neurodegenerative diseases (dementias including Alzheimer’s type).</p>
</fn>
<fn id="t003fn004">
<p>HR denotes hazard ratio from the Cox proportional hazards regression model.</p>
</fn>
<fn id="t003fn005">
<p>CI denotes confidence interval</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Kaplan-Meier survival curves (<xref ref-type="fig" rid="pgen.1006314.g001">Fig 1A–1C</xref>) suggest that in ARIC and each FHS cohort the rs222826_T allele carriers can be at antagonistic risks of CHD at different ages. They can be protected against early onset CHD and be at risk of later onset CHD. These antagonistic effects are most pronounced in the FHS original cohort. This heterogeneity implies that the estimates of the risks in this cohort are biased because of disproportional hazards. Correcting for this heterogeneity by focusing on individuals with onset of CHD at 65 years and older (<xref ref-type="fig" rid="pgen.1006314.g001">Fig 1D</xref>), the effect size in the FHS original cohort becomes nearly the same as in ARIC and attains suggestive significance, HR = 1.50, <italic>p</italic> = 7.9×10<sup>−2</sup>.</p>
<fig id="pgen.1006314.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Probability of remaining free of coronary heart disease (CHD) for the rs222826_T allele carriers.</title>
<p>(A) The Atherosclerosis Risk in Communities Study (ARIC), (B, D) the Framingham Heart Study (FHS) original (FHS_C1) cohort, (C) the FHS Offspring (FHSO) cohort. HR denotes hazard ratio, HR<sub>all</sub> in panel (B) denotes the estimates for the entire FHS_C1 sample. HR<sub>65+</sub> in (D) denotes the estimates for onsets of CHD at ages 65 years and older. N = n/m denotes the size of the entire sample (n) and the number of CHD cases (m) for major allele homozygotes (CC, blue color) and minor allele carriers (CT+TT, red color). P shows p-values.</p>
</caption>
<graphic xlink:href="pgen.1006314.g001"></graphic>
</fig>
</sec>
<sec id="sec005">
<title>The rs222826_T allele and risk of neurodegenerative diseases</title>
<p>Given old ages of the genotyped participants of the FHS original cohort, we tested the association of the rs222826_T allele with ND. <xref ref-type="table" rid="pgen.1006314.t003">Table 3</xref> shows that this allele is significantly associated with ND as well.</p>
</sec>
<sec id="sec006">
<title>Do biomarkers mediate genetic associations with diseases and death?</title>
<p>To address this question, we conducted causal mediation analysis (see <xref ref-type="sec" rid="sec014">Methods</xref>). First, we evaluated the associations of the minor allele with the selected biomarkers in each study. The analyses show significant and marginally significant associations of this allele with HDL-C (<italic>β</italic> = -3.8, <italic>p</italic> = 4.7×10<sup>−3</sup>) and TG (<italic>β</italic> = 6.6, <italic>p</italic> = 3.3×10<sup>−3</sup>) in ARIC and BMI (<italic>β</italic> = -3.4, <italic>p</italic> = 5.7×10<sup>−2</sup>) in the FHS original cohort (<xref ref-type="supplementary-material" rid="pgen.1006314.s003">S1 Table</xref>). Then, we evaluated mediating roles of these biomarkers in effects between rs222826 and risks of the selected diseases and death.</p>
<p>The analysis in ARIC (<xref ref-type="table" rid="pgen.1006314.t004">Table 4</xref>) showed significant indirect effects of HDL-C and TG in associations of rs222826 with the risks of majority of diseases and death, except cancer (HDL-C and TG) and diabetes (TG). The sizes of these indirect effects were, however, substantially smaller than those of “direct” effects (direct effect means the effect not through the selected mediator). Accordingly, significant mediating effects of lipids explained only a small fraction of the total genetic effects (they are given in Tables <xref ref-type="table" rid="pgen.1006314.t002">2</xref> and <xref ref-type="table" rid="pgen.1006314.t003">3</xref>).</p>
<table-wrap id="pgen.1006314.t004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t004</object-id>
<label>Table 4</label>
<caption>
<title>Causal mediation analyses: the role of lipids and BMI in the effects of the rs222826_T allele on risks of diseases and death in the ARIC and the FHS original cohort.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t004g" xlink:href="pgen.1006314.t004"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" colspan="1" rowspan="3">Outcome</th>
<th align="justify" colspan="4" rowspan="1">ARIC, mediator HDL-C</th>
<th align="justify" colspan="4" rowspan="1">ARIC, mediator TG</th>
<th align="justify" colspan="4" rowspan="1">FHS_C1, mediator BMI</th>
</tr>
<tr>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
</tr>
<tr>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" colspan="1" rowspan="1">CHD<xref ref-type="table-fn" rid="t004fn005"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">1.66</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.05</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.66</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.04</td>
<td align="center" colspan="1" rowspan="1">1.6E-2</td>
<td align="center" colspan="1" rowspan="1">1.52</td>
<td align="center" colspan="1" rowspan="1">1.0E-1</td>
<td align="center" colspan="1" rowspan="1">.989</td>
<td align="center" colspan="1" rowspan="1">4.9E-1</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">HF</td>
<td align="center" colspan="1" rowspan="1">1.48</td>
<td align="center" colspan="1" rowspan="1">2.4E-2</td>
<td align="center" colspan="1" rowspan="1">1.04</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.47</td>
<td align="center" colspan="1" rowspan="1">2.4E-2</td>
<td align="center" colspan="1" rowspan="1">1.05</td>
<td align="center" colspan="1" rowspan="1">8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.48</td>
<td align="center" colspan="1" rowspan="1">8.8E-2</td>
<td align="center" colspan="1" rowspan="1">.958</td>
<td align="center" colspan="1" rowspan="1">3.2E-2</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Stroke</td>
<td align="center" colspan="1" rowspan="1">1.16</td>
<td align="center" colspan="1" rowspan="1">6.2E-1</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.13</td>
<td align="center" colspan="1" rowspan="1">6.2E-1</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.94</td>
<td align="center" colspan="1" rowspan="1">5.6E-2</td>
<td align="center" colspan="1" rowspan="1">.968</td>
<td align="center" colspan="1" rowspan="1">1.9E-1</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Diabetes</td>
<td align="center" colspan="1" rowspan="1">1.28</td>
<td align="center" colspan="1" rowspan="1">1.0E-1</td>
<td align="center" colspan="1" rowspan="1">1.07</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.33</td>
<td align="center" colspan="1" rowspan="1">7.2E-2</td>
<td align="center" colspan="1" rowspan="1">1.02</td>
<td align="center" colspan="1" rowspan="1">4.0E-1</td>
<td align="center" colspan="1" rowspan="1">.752</td>
<td align="center" colspan="1" rowspan="1">3.0E-1</td>
<td align="center" colspan="1" rowspan="1">.953</td>
<td align="center" colspan="1" rowspan="1">4.8E-2</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Cancer</td>
<td align="center" colspan="1" rowspan="1">1.19</td>
<td align="center" colspan="1" rowspan="1">1.7E-1</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">4.2E-1</td>
<td align="center" colspan="1" rowspan="1">1.18</td>
<td align="center" colspan="1" rowspan="1">2.1E-1</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">4.3E-1</td>
<td align="center" colspan="1" rowspan="1">1.23</td>
<td align="center" colspan="1" rowspan="1">3.8E-1</td>
<td align="center" colspan="1" rowspan="1">.998</td>
<td align="center" colspan="1" rowspan="1">9.5E-1</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">ND</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">1.94</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">.958</td>
<td align="center" colspan="1" rowspan="1">1.6E-2</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Death</td>
<td align="center" colspan="1" rowspan="1">1.28</td>
<td align="center" colspan="1" rowspan="1">3.2E-2</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.25</td>
<td align="center" colspan="1" rowspan="1">5.6E-2</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">2.4E-2</td>
<td align="center" colspan="1" rowspan="1">1.47</td>
<td align="center" colspan="1" rowspan="1">8.0E-3</td>
<td align="center" colspan="1" rowspan="1">.981</td>
<td align="center" colspan="1" rowspan="1">1.6E-1</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001">
<p>HDL-C = high-density lipoprotein cholesterol; TG = triglycerides; CHD = coronary heart disease; HF = heart failure; ND = neurodegenerative diseases (dementias including Alzheimer’s type).</p>
</fn>
<fn id="t004fn002">
<p>“Direct” (“Indirect”) implies the effect of the rs222826_T allele on an outcome not through (through) a given mediator, i.e., HDL-C or TG in ARIC and BMI in FHS original (FHS_C1) cohort.</p>
</fn>
<fn id="t004fn003">
<p>HDL-C and BMI were tested for potential mediation effects given their significant associations with the rs222826_T allele in respective studies (<xref ref-type="supplementary-material" rid="pgen.1006314.s003">S1 Table</xref>).</p>
</fn>
<fn id="t004fn004">
<p>HR denotes hazard ratio from the Cox proportional hazards regression model.</p>
</fn>
<fn id="t004fn005">
<p><sup>a</sup> To correct for disproportionality of hazards, the estimate in the FHS_C1 (original) cohort is given for onset of CHD at ages 65 years and older.</p>
</fn>
<fn id="t004fn006">
<p>NA = not available</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The analyses in the FHS original cohort show significant indirect effects of the rs222826_T allele on risks of HF, diabetes, and ND through BMI (<xref ref-type="table" rid="pgen.1006314.t004">Table 4</xref>). As in ARIC, these effects also represented a small fraction of the total effects. However, unlike ARIC, the HRs for the indirect effects were less than one for all diseases. Because the minor allele showed protective effect against diabetes in this cohort (HR = 0.71, <italic>p</italic> = 2.3×10<sup>−1</sup>, <xref ref-type="table" rid="pgen.1006314.t003">Table 3</xref>), this indirect effect implied that the association of the minor allele with BMI partly mediated (explained) the association of this allele with diabetes. For HF and ND, conditioning on BMI amplified detrimental effects between the rs222826_T allele and these diseases (compare Tables <xref ref-type="table" rid="pgen.1006314.t003">3</xref> and <xref ref-type="table" rid="pgen.1006314.t005">5</xref>) because of explicating a fraction of BMI-related genetic heterogeneity.</p>
<table-wrap id="pgen.1006314.t005" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t005</object-id>
<label>Table 5</label>
<caption>
<title>Hazard ratios for HF, ND and death for the minor allele of rs222826 or rs222827 SNPs and potential endophenotypes in the FHS original cohort and HRS.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t005g" xlink:href="pgen.1006314.t005"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Outcome</th>
<th align="left" colspan="1" rowspan="1">Study</th>
<th align="left" colspan="1" rowspan="1">Predictor</th>
<th align="center" colspan="1" rowspan="1">Sample</th>
<th align="center" colspan="1" rowspan="1">HR</th>
<th align="center" colspan="1" rowspan="1">95% CI</th>
<th align="center" colspan="1" rowspan="1">p</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">HF</td>
<td align="left" colspan="1" rowspan="1">FHS_C1</td>
<td align="left" colspan="1" rowspan="1">rs222826_T</td>
<td align="center" colspan="1" rowspan="1">All</td>
<td align="center" colspan="1" rowspan="1">1.52</td>
<td align="center" colspan="1" rowspan="1">0.94–2.46</td>
<td align="center" colspan="1" rowspan="1">9.0E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">BMI</td>
<td align="center" colspan="1" rowspan="1">All</td>
<td align="center" colspan="1" rowspan="1">1.05</td>
<td align="center" colspan="1" rowspan="1">1.02–1.09</td>
<td align="center" colspan="1" rowspan="1">2.0E-3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">FHS_C1</td>
<td align="left" colspan="1" rowspan="1">rs222826_T</td>
<td align="center" colspan="1" rowspan="1">All</td>
<td align="center" colspan="1" rowspan="1">2.00</td>
<td align="center" colspan="1" rowspan="1">1.31–3.06</td>
<td align="center" colspan="1" rowspan="1">1.3E-3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">BMI</td>
<td align="center" colspan="1" rowspan="1">All</td>
<td align="center" colspan="1" rowspan="1">1.04</td>
<td align="center" colspan="1" rowspan="1">1.01–1.08</td>
<td align="center" colspan="1" rowspan="1">1.7E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Death</td>
<td align="left" colspan="1" rowspan="1">HRS</td>
<td align="left" colspan="1" rowspan="1">rs222827_A</td>
<td align="center" colspan="1" rowspan="1">All</td>
<td align="center" colspan="1" rowspan="1">1.32</td>
<td align="center" colspan="1" rowspan="1">1.01–1.71</td>
<td align="center" colspan="1" rowspan="1">3.9E-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Cancer</td>
<td align="center" colspan="1" rowspan="1">All</td>
<td align="center" colspan="1" rowspan="1">1.29</td>
<td align="center" colspan="1" rowspan="1">1.15–1.45</td>
<td align="center" colspan="1" rowspan="1">1.4E-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">rs222827_A</td>
<td align="center" colspan="1" rowspan="1">Cancer free</td>
<td align="center" colspan="1" rowspan="1">1.51</td>
<td align="center" colspan="1" rowspan="1">1.12–2.03</td>
<td align="center" colspan="1" rowspan="1">6.7E-3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">rs222827_A</td>
<td align="center" colspan="1" rowspan="1">With cancer</td>
<td align="center" colspan="1" rowspan="1">0.92</td>
<td align="center" colspan="1" rowspan="1">0.53–1.61</td>
<td align="center" colspan="1" rowspan="1">7.8E-1</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t005fn001">
<p>FHS_C1 = the Framingham Heart Study (FHS) original cohort and HRS = the Health and Retirement Study.</p>
</fn>
<fn id="t005fn002">
<p>HF = heart failure; ND = neurodegenerative diseases (dementias including Alzheimer’s type).</p>
</fn>
<fn id="t005fn003">
<p>HR denotes hazard ratio from the Cox proportional hazards regression model.</p>
</fn>
<fn id="t005fn004">
<p>CI denotes confidence interval</p>
</fn>
<fn id="t005fn005">
<p>All: the models were fitted in the entire samples to estimate additive effects of the minor allele and: (i) BMI measured in kg/m<sup>2</sup> in FHS and (ii) cancer in HRS.</p>
</fn>
<fn id="t005fn006">
<p>Rows “Cancer free” and “With cancer” show the results in the HRS samples stratified by cancer status.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec007">
<title>Do diseases mediate genetic associations with death?</title>
<p><xref ref-type="table" rid="pgen.1006314.t006">Table 6</xref> shows that CHD, HF, and diabetes significantly mediate the risk of death for the rs222826_T allele carriers in ARIC. Diabetes explained 12.5%,—i.e., 4% (HR = 1.04, see <xref ref-type="table" rid="pgen.1006314.t006">Table 6</xref>) of 32% (HR = 1.32, see <xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref>),—of the death risk. CHD or HF explained 28.1% of the death risk. Mediating effect of either of these diseases (CHD, HF, or diabetes) was also highly significant (HR = 1.11, <italic>p</italic>&lt;8.0×10<sup>−3</sup>) explaining about 34.4% of the death risk.</p>
<table-wrap id="pgen.1006314.t006" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t006</object-id>
<label>Table 6</label>
<caption>
<title>Causal mediation analyses: the role of diseases-endophenotypes in the effect of the minor allele of rs222826 <xref ref-type="table-fn" rid="t006fn001"><sup>a</sup></xref> SNP on risk of death in ARIC, FHS cohorts, and HRS.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t006g" xlink:href="pgen.1006314.t006"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" colspan="1" rowspan="3">Mediator</th>
<th align="justify" colspan="4" rowspan="1">ARIC</th>
<th align="justify" colspan="4" rowspan="1">FHS_C1</th>
<th align="justify" colspan="4" rowspan="1">FHSO</th>
<th align="justify" colspan="4" rowspan="1">HRS<xref ref-type="table-fn" rid="t006fn001"><sup>a</sup></xref></th>
</tr>
<tr>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
<th align="justify" colspan="2" rowspan="1">Direct</th>
<th align="justify" colspan="2" rowspan="1">Indirect</th>
</tr>
<tr>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
<th align="justify" colspan="1" rowspan="1">HR</th>
<th align="justify" colspan="1" rowspan="1">p</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" colspan="1" rowspan="1">CHD</td>
<td align="center" colspan="1" rowspan="1">1.22</td>
<td align="center" colspan="1" rowspan="1">1.5E-1</td>
<td align="center" colspan="1" rowspan="1">1.09</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.42</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">7.7E-1</td>
<td align="center" colspan="1" rowspan="1">1.88</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">9.4E-1</td>
<td align="center" colspan="1" rowspan="1">1.30</td>
<td align="center" colspan="1" rowspan="1">7.2E-2</td>
<td align="center" colspan="1" rowspan="1">1.01</td>
<td align="center" colspan="1" rowspan="1">4.2E-1</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">CHD<sub>65+</sub><xref ref-type="table-fn" rid="t006fn006"><sup>b</sup></xref></td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">1.44</td>
<td align="center" colspan="1" rowspan="1">4.8E-2</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">6.9E-1</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">HF</td>
<td align="center" colspan="1" rowspan="1">1.20</td>
<td align="center" colspan="1" rowspan="1">2.0E-1</td>
<td align="center" colspan="1" rowspan="1">1.09</td>
<td align="center" colspan="1" rowspan="1">2.4E-2</td>
<td align="center" colspan="1" rowspan="1">1.43</td>
<td align="center" colspan="1" rowspan="1">1.6E-2</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">8.9E-1</td>
<td align="center" colspan="1" rowspan="1">1.82</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">1.3E-1</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Stroke</td>
<td align="center" colspan="1" rowspan="1">1.30</td>
<td align="center" colspan="1" rowspan="1">2.4E-2</td>
<td align="center" colspan="1" rowspan="1">1.01</td>
<td align="center" colspan="1" rowspan="1">5.7E-1</td>
<td align="center" colspan="1" rowspan="1">1.39</td>
<td align="center" colspan="1" rowspan="1">4.0E-2</td>
<td align="center" colspan="1" rowspan="1">1.02</td>
<td align="center" colspan="1" rowspan="1">5.6E-2</td>
<td align="center" colspan="1" rowspan="1">1.83</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">2.4E-1</td>
<td align="center" colspan="1" rowspan="1">1.31</td>
<td align="center" colspan="1" rowspan="1">4.8E-2</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">9.2E-1</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">DM</td>
<td align="center" colspan="1" rowspan="1">1.26</td>
<td align="center" colspan="1" rowspan="1">1.3E-1</td>
<td align="center" colspan="1" rowspan="1">1.04</td>
<td align="center" colspan="1" rowspan="1">4.0E-2</td>
<td align="center" colspan="1" rowspan="1">1.45</td>
<td align="center" colspan="1" rowspan="1">1.6E-2</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">8.6E-1</td>
<td align="center" colspan="1" rowspan="1">1.84</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.02</td>
<td align="center" colspan="1" rowspan="1">5.6E-2</td>
<td align="center" colspan="1" rowspan="1">1.27</td>
<td align="center" colspan="1" rowspan="1">1.1E-1</td>
<td align="center" colspan="1" rowspan="1">1.02</td>
<td align="center" colspan="1" rowspan="1">8.0E-3</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Cancer</td>
<td align="center" colspan="1" rowspan="1">1.30</td>
<td align="center" colspan="1" rowspan="1">3.2E-2</td>
<td align="center" colspan="1" rowspan="1">1.01</td>
<td align="center" colspan="1" rowspan="1">1.7E-1</td>
<td align="center" colspan="1" rowspan="1">1.41</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">7.2E-1</td>
<td align="center" colspan="1" rowspan="1">1.83</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="center" colspan="1" rowspan="1">5.2E-1</td>
<td align="center" colspan="1" rowspan="1">1.31</td>
<td align="center" colspan="1" rowspan="1">2.4E-2</td>
<td align="center" colspan="1" rowspan="1">0.99</td>
<td align="center" colspan="1" rowspan="1">4.0E-2</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">ND</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">1.51</td>
<td align="center" colspan="1" rowspan="1">8.0E-3</td>
<td align="center" colspan="1" rowspan="1">1.00</td>
<td align="center" colspan="1" rowspan="1">8.7E-1</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">CHD/HF/DM</td>
<td align="center" colspan="1" rowspan="1">1.24</td>
<td align="center" colspan="1" rowspan="1">1.1E-1</td>
<td align="center" colspan="1" rowspan="1">1.11</td>
<td align="center" colspan="1" rowspan="1">&lt;8.0E-3</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
<td align="center" colspan="1" rowspan="1">NA</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t006fn001">
<p><sup>a</sup> HRS SNP used is proxy SNP rs222827</p>
</fn>
<fn id="t006fn002">
<p>CHD = coronary heart disease; CHD<sub>65+</sub> = coronary heart disease with onset at 65 years and older; HF = heart failure; DM = diabetes mellitus; ND = neurodegenerative diseases (dementias including Alzheimer’s type).</p>
</fn>
<fn id="t006fn003">
<p>“Direct” (“Indirect”) implies the effect of the rs222826_T allele on risk of death not through (through) a mediator given in column “Mediator.”</p>
</fn>
<fn id="t006fn004">
<p>HR denotes hazard ratio from the Cox proportional hazards regression model.</p>
</fn>
<fn id="t006fn005">
<p>CHD/HF/DM denotes the analysis of mediating effect of either of these diseases, i.e., if a person has CHD, or HF, or DM.</p>
</fn>
<fn id="t006fn006">
<p><sup>b</sup> To correct for disproportionality in hazards, the estimate in the FHS_C1 (original) cohort is given for onset of CHD at ages 65 years and older.</p>
</fn>
<fn id="t006fn007">
<p>NA = not available or not estimated</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In FHS (<xref ref-type="table" rid="pgen.1006314.t006">Table 6</xref>), only stroke (FHS_C1) and diabetes (FHSO) showed small, marginally significant mediating effects between the rs222826_T allele and risk of death.</p>
<p>In HRS, the minor allele showed small but significant indirect effects on risk of death through diabetes and cancer (<xref ref-type="table" rid="pgen.1006314.t006">Table 6</xref>). Indirect effect through diabetes was of mediating nature explaining a small fraction (6.7%) of the total risk of death. Cancer showed moderating effect amplifying the total risk of death for the minor allele carriers in additive and multiplicative approximations (<xref ref-type="table" rid="pgen.1006314.t005">Table 5</xref>).</p>
</sec>
<sec id="sec008">
<title>Pooled effects of the rs222826_T allele on diseases and death and their combined significance</title>
<p>Explicating age-related heterogeneity in the above sections helped in gaining further insights into genetic predisposition to diseases and death and, as a result, in improving estimates of the effects of the minor allele on these outcomes. Accordingly, pooling genetic effects in different populations should leverage these insights.</p>
<p><xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> shows the results of meta-analyses leveraging information from the analyses of age-related heterogeneity in FHS (<xref ref-type="table" rid="pgen.1006314.t003">Table 3</xref>) and causal inferences (<xref ref-type="table" rid="pgen.1006314.t005">Table 5</xref>). These analyses leveraged also potential substantial basis of antagonistic effects for diabetes (see sections “<bold><xref ref-type="sec" rid="sec004">Explicating age-related genetic heterogeneity in the FHS</xref></bold>” above and “<bold><xref ref-type="sec" rid="sec011">The role of endophenotypes</xref></bold>” in the <xref ref-type="sec" rid="sec009">Discussion</xref>) by pooling evidences for the effects in different FHS cohorts disregarding the effect directions. Meta-analysis of detrimental effects for diabetes, which are seen in younger individuals only, gives HR = 1.35, <italic>p</italic> = 3.3×10<sup>−4</sup>. Further, significant antagonistic effects for cancer in different studies imply significant heterogeneity (e.g., evidenced by non-overlapping 95% CI in <xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref> for cancer estimates in FHS and HRS). Accordingly, the result of meta-analysis in this case was presented in <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> disregarding the effect directions. An estimate for cancer in more homogeneous samples of ARIC and FHS is HR = 1.23, <italic>p</italic> = 1.4×10<sup>−2</sup>. For comparison, <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> also provides estimates without leveraging all this information.</p>
<table-wrap id="pgen.1006314.t007" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.t007</object-id>
<label>Table 7</label>
<caption>
<title>The results of meta-analyses of the effects of the minor allele of rs222826 <xref ref-type="table-fn" rid="t007fn001"><sup>a</sup></xref> SNP on risks of diseases and death.</title>
</caption>
<alternatives>
<graphic id="pgen.1006314.t007g" xlink:href="pgen.1006314.t007"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" colspan="1" rowspan="1">Outcome</th>
<th align="center" colspan="3" rowspan="1">With improvements</th>
<th align="center" colspan="3" rowspan="1">No improvements</th>
</tr>
<tr>
<th align="justify" colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">Exp(β)</th>
<th align="center" colspan="1" rowspan="1">95% CI</th>
<th align="center" colspan="1" rowspan="1">p-value</th>
<th align="center" colspan="1" rowspan="1">Exp(β)</th>
<th align="center" colspan="1" rowspan="1">95% CI</th>
<th align="center" colspan="1" rowspan="1">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" colspan="1" rowspan="1">CHD</td>
<td align="center" colspan="1" rowspan="1">1.35</td>
<td align="center" colspan="1" rowspan="1">1.18–1.54</td>
<td align="center" colspan="1" rowspan="1">8.9E-06</td>
<td align="center" colspan="1" rowspan="1">1.32</td>
<td align="center" colspan="1" rowspan="1">1.16–1.50</td>
<td align="center" colspan="1" rowspan="1">3.1E-05</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">HF</td>
<td align="center" colspan="1" rowspan="1">1.55</td>
<td align="center" colspan="1" rowspan="1">1.24–1.93</td>
<td align="center" colspan="1" rowspan="1">9.7E-05</td>
<td align="center" colspan="1" rowspan="1">1.51</td>
<td align="center" colspan="1" rowspan="1">1.21–1.88</td>
<td align="center" colspan="1" rowspan="1">2.4E-04</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Stroke</td>
<td align="center" colspan="1" rowspan="1">1.25</td>
<td align="center" colspan="1" rowspan="1">1.01–1.55</td>
<td align="center" colspan="1" rowspan="1">4.0E-02</td>
<td align="center" colspan="1" rowspan="1">1.25</td>
<td align="center" colspan="1" rowspan="1">1.01–1.55</td>
<td align="center" colspan="1" rowspan="1">4.0E-02</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Diabetes</td>
<td align="center" colspan="1" rowspan="1">1.36</td>
<td align="center" colspan="1" rowspan="1">1.16–1.60</td>
<td align="center" colspan="1" rowspan="1">1.6E-04</td>
<td align="center" colspan="1" rowspan="1">1.22</td>
<td align="center" colspan="1" rowspan="1">1.04–1.43</td>
<td align="center" colspan="1" rowspan="1">1.5E-02</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Cancer</td>
<td align="center" colspan="1" rowspan="1">1.25</td>
<td align="center" colspan="1" rowspan="1">1.09–1.44</td>
<td align="center" colspan="1" rowspan="1">1.8E-03</td>
<td align="center" colspan="1" rowspan="1">1.08</td>
<td align="center" colspan="1" rowspan="1">0.93–1.25</td>
<td align="center" colspan="1" rowspan="1">3.0E-01</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">ND</td>
<td align="center" colspan="1" rowspan="1">2.00</td>
<td align="center" colspan="1" rowspan="1">1.31–3.05</td>
<td align="center" colspan="1" rowspan="1">1.3E-03</td>
<td align="center" colspan="1" rowspan="1">1.89</td>
<td align="center" colspan="1" rowspan="1">1.24–2.87</td>
<td align="center" colspan="1" rowspan="1">2.9E-3</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Death</td>
<td align="center" colspan="1" rowspan="1">1.49</td>
<td align="center" colspan="1" rowspan="1">1.30–1.70</td>
<td align="center" colspan="1" rowspan="1">4.6E-09</td>
<td align="center" colspan="1" rowspan="1">1.44</td>
<td align="center" colspan="1" rowspan="1">1.27–1.64</td>
<td align="center" colspan="1" rowspan="1">3.8E-08</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1">Combined pleiotropic effects p-value</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">6.6E-21</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">8.3E-14</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t007fn001">
<p><sup>a</sup> HRS SNP used is proxy SNP rs222827</p>
</fn>
<fn id="t007fn002">
<p>CHD = coronary heart disease; HF = heart failure; ND = neurodegenerative diseases (dementias including Alzheimer’s type).</p>
</fn>
<fn id="t007fn003">
<p>Columns “No improvements” (“With improvements”) present the results of meta-analyses without (with) leveraging information from the analyses of age-related heterogeneity and causal inferences.</p>
</fn>
<fn id="t007fn004">
<p>“Combined pleiotropic effects p-value” is p-value from the Fisher’s combined probability test estimating the global null hypothesis that neither of genetic associations with risks of diseases or death is true.</p>
</fn>
<fn id="t007fn005">
<p>The sources of information and numerical estimates of the effect estimates used in these meta-analyses are given in <xref ref-type="supplementary-material" rid="pgen.1006314.s004">S2</xref>–<xref ref-type="supplementary-material" rid="pgen.1006314.s007">S5</xref> Tables.</p>
</fn>
<fn id="t007fn006">
<p>Exp(β) is exponent of the effect size beta.</p>
</fn>
<fn id="t007fn007">
<p>CI denotes confidence interval</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p><xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> shows pleiotropic associations of the minor allele with risks of all major diseases and death. Combining <italic>p</italic>-values for these pleiotropic associations into a single <italic>p</italic>-value using the Fisher’s test [<xref ref-type="bibr" rid="pgen.1006314.ref027">27</xref>], the global null hypothesis that neither of these associations is true is <italic>p</italic> = 6.6×10<sup>−21</sup>. Following meta-analysis without leveraging additional information the estimate is still highly convincing <italic>p</italic> = 8.3×10<sup>−14</sup>. This test provides inflated estimates because it disregards potential correlation of the association signals. However, this is a reasonable approximation for the combined significance of the pleiotropic effects of the minor allele because this <italic>p</italic>-value aggregates the estimates from independent studies.</p>
</sec>
</sec>
<sec id="sec009" sec-type="conclusions">
<title>Discussion</title>
<p>This paper reports on strong associations of previously non-reported SNPs, rs222826 and its proxy rs222827, located on chromosome 2 in band q22.3, with phenotypes characterizing healthspan (risks of major human diseases including CHD, HF, stroke, diabetes, cancer, and ND) and lifespan (risk of death) in four cohorts from three studies, ARIC, FHS, and HRS. To comprehensively characterize these associations, we adopted an analytic strategy which leveraged the analysis of age-related heterogeneity (this concept is detailed in the Introduction), causal mediation analysis, and information on pleiotropic effects.</p>
<sec id="sec010">
<title>Age-related heterogeneity</title>
<p>Our initial findings (<xref ref-type="table" rid="pgen.1006314.t002">Table 2</xref>) show consistent and significant associations of the minor allele (rs222826_T in ARIC and FHS and rs222827_A in HRS) with risks of death in each study but dissimilar associations of this allele with diseases.</p>
<p>Dissimilar associations in different studies may reflect differences in biodemographic structures in these studies [<xref ref-type="bibr" rid="pgen.1006314.ref028">28</xref>]. The results of the analyses of age-related heterogeneity in the FHS (<xref ref-type="table" rid="pgen.1006314.t003">Table 3</xref>) support this mechanism of non-replication of the genetic associations with risks of diabetes and CHD. Indeed, explicating antagonistic effects between the rs222826_T allele and risk of diabetes in two FHS cohorts shows a striking result that the detrimental effect of this allele is actually the same in three younger cohorts (ARIC, FHSO, and HRS) of individuals born in about the same time period around the 1930s-1940s. The effect is opposite (protective) in substantially older population with mean birth year around the 1910s. For CHD, we observe antagonistic risks at different ages, which cause biased estimates in the models based on the assumption of proportional hazards (<xref ref-type="fig" rid="pgen.1006314.g001">Fig 1</xref>). Explicating this age-related heterogeneity by focusing on onset of CHD at later ages in the FHS original cohort detected replicating signal. Importantly, the effect size in this case becomes comparable with the effect size in the association of the rs222826_T allele with CHD in ARIC.</p>
<p>Accumulating evidence suggests the importance of age-related heterogeneity in genetic effects. The analyses highlighted the role of age in genetic regulation of BMI [<xref ref-type="bibr" rid="pgen.1006314.ref029">29</xref>], sensitivity of the effects of longevity alleles to birth cohorts [<xref ref-type="bibr" rid="pgen.1006314.ref030">30</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref031">31</xref>], sensitivity of genetic associations with lipids to chronological age [<xref ref-type="bibr" rid="pgen.1006314.ref032">32</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref033">33</xref>], changes in the allele frequencies with age [<xref ref-type="bibr" rid="pgen.1006314.ref034">34</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref035">35</xref>], antagonistic risks of diseases and death [<xref ref-type="bibr" rid="pgen.1006314.ref016">16</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref032">32</xref>].</p>
<p>An important result of these analyses is that they highlight potential non-stochastic mechanisms, which can contribute to non-replication of genetic associations. Clearly, biodemographic factors are not the only ones that can cause non-replication; other factors (e.g., GxG interactions [<xref ref-type="bibr" rid="pgen.1006314.ref014">14</xref>]) may play a role.</p>
</sec>
<sec id="sec011">
<title>The role of endophenotypes</title>
<p>Causal mediation analyses showed that three biomarkers-endophenotypes (HDL-C and TG in ARIC and BMI in the FHS original cohort) significantly moderated the effects between the rs222826_T allele and risks of several diseases and death. They, however, accounted for a small fraction of the genetic effects implying that the major fraction of these effects is not through the selected biomarkers.</p>
<p>As expected, lipids showed significant mediating effects explaining a fraction of the total detrimental effects on cardiovascular diseases in ARIC.</p>
<p>Favorable association of the rs222826_T allele with BMI in the FHS original cohort partly explained its favorable association with risk of diabetes in the same cohort (<xref ref-type="table" rid="pgen.1006314.t004">Table 4</xref>). This result emphasizes real nature of the protective (though insignificant) effect of this allele on diabetes. It also shows that favorable associations with diabetes and BMI are characteristic for older people from early birth cohorts (represented by the FHS original cohort). The lack of favorable associations with BMI and the presence of detrimental associations with diabetes in younger cohorts (see the above section) may indicate change in the mechanisms connecting this allele with diabetes in older and younger cohorts [<xref ref-type="bibr" rid="pgen.1006314.ref010">10</xref>]. This change is consistent with recent trend on increase of incidence of diabetes [<xref ref-type="bibr" rid="pgen.1006314.ref036">36</xref>].</p>
<p>We also found that BMI was a significant moderator in the FHS original cohort amplifying effects between the rs222826_T allele and HF or ND. This moderation effect implies that favorable association of this allele with BMI (<xref ref-type="supplementary-material" rid="pgen.1006314.s003">S1 Table</xref>) can partly mitigate detrimental effects of this allele on HF and ND (compare Tables <xref ref-type="table" rid="pgen.1006314.t003">3</xref> and <xref ref-type="table" rid="pgen.1006314.t005">5</xref>). Interestingly, this analysis suggests that BMI can be involved in a pathway linking the rs222826_T allele with ND. This is in line with findings in large epidemiological studies reported on association of BMI with ND [<xref ref-type="bibr" rid="pgen.1006314.ref037">37</xref>], that is also seen in the FHS original cohort (<xref ref-type="table" rid="pgen.1006314.t005">Table 5</xref>).</p>
<p>The mediation analysis of indirect effects of the rs222826_T allele on risks of death through diseases-endophenotypes (<xref ref-type="table" rid="pgen.1006314.t006">Table 6</xref>) provided strongest evidence for significant mediating effects of CHD, HF, and diabetes in ARIC. Combined mediating effect of these diseases explained about 34.4% of the death risk. Other diseases in ARIC, FHS, and HRS either mediated substantially smaller fractions of the total effect or did not mediate it at all.</p>
<p>We found that the rs222827_A allele and cancer increase the risk of death in HRS additively (<xref ref-type="table" rid="pgen.1006314.t005">Table 5</xref>). However, cancer patients who carry and do not carry this allele show the same survival. This result indicates that detrimental effect of this allele on risk of death can be partly mitigated by (unknown) genetic and/or environmental factors.</p>
<p>Thus, the results from the causal mediation analyses indicate that most of the effects between the minor allele and risks of diseases and death are only partly explained by the selected endophenotypes. These results suggest that such a wide impact of this allele on phenotypes with major contribution to healthspan and lifespan may indicate connections of this variant with some fundamental biological mechanisms (see below) that is in line with the concept of geroscience [<xref ref-type="bibr" rid="pgen.1006314.ref021">21</xref>]. Modulation of the effects by age-related heterogeneity and endophenotypes suggests a role of other factors (other genes and/or environment) in the effects of this allele.</p>
</sec>
<sec id="sec012">
<title>Leveraging analyses of age-related heterogeneity, causal inferences, and pleiotropic effects</title>
<p>A “side effect” of gaining insights into intermediate mechanisms connecting genes with major phenotypes contributing to healthspan and lifespan discussed above is improving statistical estimates (<xref ref-type="table" rid="pgen.1006314.t005">Table 5</xref>). Indeed, <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> shows improvement in overall significance of the combined pleiotropic effect of the minor allele by seven orders of magnitude from <italic>p</italic> = 8.3×10<sup>−14</sup> to <italic>p</italic> = 6.6×10<sup>−21</sup>. The minor allele increases risks of death by about 50%; this estimate is genome-wide significant (<italic>p</italic> = 4.6×10<sup>−9</sup>). In addition, the same allele increases risks of CHD by 35% (<italic>p</italic> = 8.9×10<sup>−6</sup>), HF by 55% (<italic>p</italic> = 9.7×10<sup>−5</sup>), stroke by 25% (<italic>p</italic> = 4.0×10<sup>−2</sup>), and ND by 100% (<italic>p</italic> = 1.3×10<sup>−3</sup>). This allele is also associated with risks of diabetes (<italic>p</italic> = 1.6×10<sup>−4</sup>) and cancer (<italic>p</italic> = 1.8×10<sup>−3</sup>). Most of its effects are detrimental as it increases risks of diabetes in younger generations from ARIC, FHSO, and HRS by 35% (HR = 1.35, <italic>p</italic> = 3.3×10<sup>−4</sup>) and risk of cancer in ARIC and FHS by 23% (HR = 1.23, <italic>p</italic> = 1.4×10<sup>−2</sup>).</p>
</sec>
<sec id="sec013">
<title>Biological role</title>
<p>The rs222826 (and its proxy in HRS, rs222827, which are 90 bp apart) SNP is an intergenic variant with MAF of about 2.5% in each of three Caucasian populations in ARIC, FHS, and HRS. This SNP is located on chromosome 2 in band q22.3, which harbors gene desert region (<xref ref-type="supplementary-material" rid="pgen.1006314.s001">S1 Fig</xref>). Studies show that gene deserts (which make up ~25% of the genome [<xref ref-type="bibr" rid="pgen.1006314.ref038">38</xref>]) exhibit characteristics suggestive of functional importance [<xref ref-type="bibr" rid="pgen.1006314.ref039">39</xref>]. Functional role of gene deserts is supported by the fact that some of them are evolutionary conserved suggesting their essential role in regulation of core vertebrate genes [<xref ref-type="bibr" rid="pgen.1006314.ref040">40</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref041">41</xref>].</p>
<p>The rs222826/rs222827 SNPs are within an evolutionary conserved gene desert region [<xref ref-type="bibr" rid="pgen.1006314.ref040">40</xref>–<xref ref-type="bibr" rid="pgen.1006314.ref042">42</xref>], which contains intergenic regulatory sequences likely involved in regulation of the expression of protein-coding flanking genes <italic>ZEB2</italic> (zinc-finger, E-box-binding homeobox-2) (-1.6 Mb) and <italic>ACVR2A</italic> (activin receptor type-2A) (+1.7 Mb). Function of <italic>ZEB2</italic> can be directed in a tissue- and age-dependent manner by long- (1.2 Mb) and short- (62 Kb) distance enhancers suggesting a conserved regulatory string of enhancers for <italic>ZEB2</italic> and possibly <italic>ACVR2A</italic> [<xref ref-type="bibr" rid="pgen.1006314.ref043">43</xref>]. Other long-range enhancers for <italic>ZEB2</italic> were also observed [<xref ref-type="bibr" rid="pgen.1006314.ref044">44</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref045">45</xref>]. These SNPs are also in LD with SNPs from nearby regulatory regions (e.g., <italic>r</italic><sup><italic>2</italic></sup> = 1 with rs222809; <xref ref-type="supplementary-material" rid="pgen.1006314.s002">S2 Fig</xref>). In addition, gene expression may be also regulated through non-coding RNAs [<xref ref-type="bibr" rid="pgen.1006314.ref046">46</xref>–<xref ref-type="bibr" rid="pgen.1006314.ref048">48</xref>].</p>
<p>The <italic>ZEB2</italic> gene functions as a regulator of transcription interacting with activated SMADs in the TGF-β signaling pathway and <italic>ACVR2A</italic> is part of a receptor complex that binds and activates SMAD transcriptional regulators. Accordingly, these genes are linked through SMAD proteins and TGF-β signaling. The <italic>ZEB2</italic> gene is one of key regulators of epithelial-to-mesenchymal transition playing a critical role in the development of neural crest and is involved in the development of other organs that are not derived from the neural crest. This gene mediates multiple pathways related to inflammation, aging and carcinogenesis [<xref ref-type="bibr" rid="pgen.1006314.ref049">49</xref>]. The <italic>ACVR2A</italic> gene takes part in many distinct pathways by mediating the functions of members of TGF-β superfamily which are involved in a variety of biological functions including development and tissue homeostasis and associated with a wide range of human diseases [<xref ref-type="bibr" rid="pgen.1006314.ref050">50</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref051">51</xref>].</p>
<p>Various mutations in <italic>ZEB2</italic> (e.g., haplo-insufficiency, gene inactivation and deletions) and deletions at 2q22-24 are associated with a Mowat–Wilson syndrome, a complex developmental disorder involving a range of physical symptoms as well as severe intellectual disorders [<xref ref-type="bibr" rid="pgen.1006314.ref045">45</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref052">52</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref053">53</xref>]. Detrimental effects caused by the deletions in chromosomal region harboring rs222826/rs222827 and by mutations in flanking genes strengthen functional role of this evolutionary conserved region [<xref ref-type="bibr" rid="pgen.1006314.ref044">44</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref054">54</xref>].</p>
<p>Potential functional importance of this gene desert is supported by the results of our analyses showing extensive pleiotropic effects on major human diseases and strong effect on human survival.</p>
</sec>
</sec>
<sec id="sec014" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec015">
<title>Data</title>
<p><bold>The ARIC Study</bold> participants [<xref ref-type="bibr" rid="pgen.1006314.ref055">55</xref>] (aged 45–64 at baseline in 1987) were randomly selected and recruited at four field centers across the U.S. We used data from four available examinations. Measurements of biomarkers were available in all examinations. Data on onsets of diseases and survival were available through 2004. Genotyping for 12,771 ARIC participants (N = 9,633 whites) was conducted using Affymetrix 6.0 arrays (1,000K SNPs).</p>
<p><bold>The FHS</bold> design has been previously described [<xref ref-type="bibr" rid="pgen.1006314.ref056">56</xref>–<xref ref-type="bibr" rid="pgen.1006314.ref058">58</xref>]. We used data from 28 examinations of the FHS original cohort (aged 28–62 years at baseline in 1948), 8 examinations of the FHS Offspring (FHSO) cohort (aged 5–65 years at baseline in 1970), and one examination of the 3<sup>rd</sup> Generation (3<sup>rd</sup> Gen) cohort (aged 21–71 at baseline in 2001). Measurements of biomarkers were available at multiple examinations in the FHS/FHSO and the baseline in the 3<sup>rd</sup> Gen cohort. Data on onsets of diseases and survival were available through 2011. Biospecimens were mostly collected in the late 1980s and through the 1990s from surviving participants [<xref ref-type="bibr" rid="pgen.1006314.ref059">59</xref>,<xref ref-type="bibr" rid="pgen.1006314.ref060">60</xref>]. Genotyping of 9,167 white FHS participants was conducted using Affymetrix 500K arrays [<xref ref-type="bibr" rid="pgen.1006314.ref058">58</xref>].</p>
<p><bold>The HRS</bold> design has been previously described [<xref ref-type="bibr" rid="pgen.1006314.ref061">61</xref>]. We used available information on biomarkers measured in 2006–2008 and on survival during follow up from 2006 (time of biospecimen collection) through 2013. The data on onsets of diseases was not available. The HRS genotyped about 2.5M SNPs for 12,507 subjects (N = 9,736 whites) using the Illumina HumanOmni 2.5 Quad chip.</p>
</sec>
<sec id="sec016">
<title>Phenotypes</title>
<p>The focus of the analyses was on risks of major human diseases available in the data including coronary heart disease (CHD), heart failure (HF), stroke, diabetes, cancer, and neurodegenerative diseases (ND, dementias including Alzheimer’s type), and risk of death. Biomarkers represented by the traditional risk factors for cardiovascular diseases were used for causal mediation analyses (see below). They included body mass index (BMI), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), systolic blood pressure (SBP), and diastolic blood pressure (DBP).</p>
</sec>
<sec id="sec017">
<title>Analysis</title>
<p>Because genetic variants may play a complex role in age-related traits (see the <xref ref-type="sec" rid="sec001">Introduction</xref>), traditional GWAS techniques, including those designed to evaluate pleiotropic associations [<xref ref-type="bibr" rid="pgen.1006314.ref020">20</xref>], may not necessarily address complexity of genetic influence on such traits [<xref ref-type="bibr" rid="pgen.1006314.ref028">28</xref>]. Accordingly, the focus of this paper was on comprehensive analyses using more detailed candidate-gene-like techniques. GWAS was used as a tool to preselect variants, which showed promising pleiotropic properties. Below we detail the analyses sketched in the flowchart in <xref ref-type="fig" rid="pgen.1006314.g002">Fig 2</xref>.</p>
<fig id="pgen.1006314.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1006314.g002</object-id>
<label>Fig 2</label>
<caption>
<title>A flowchart of the analyses in this study.</title>
<p>All analyses were conducted for whites. Major focus of these analyses was on two uncommon SNPs with minor allele frequency (MAF) ~2.5%. Given this MAF and the available sample size in ARIC, FHS, and HRS, the analyses were conducted for men and women combined to increase the sample of the minor allele carriers.</p>
</caption>
<graphic xlink:href="pgen.1006314.g002"></graphic>
</fig>
<sec id="sec018">
<title>Pre-selection</title>
<p>We conducted univariate genome-wide scan using <italic>plink</italic> [<xref ref-type="bibr" rid="pgen.1006314.ref062">62</xref>] with the ARIC data set only to preselect SNPs with potential pleiotropic effects. We investigated 15 phenotypes for this scan including BMI, SBP, DBP, TC, HDL-C, TG, ventricular rate, hematocrit, atrial fibrillation, CHD, HF, stroke, cancer, diabetes, and death. Diseases and death were considered as binary outcomes. Linear and logistic regression models were fitted for continuous (baselines measurements were used) and binary outcomes, respectively. These models were adjusted for age, sex, and field center. No other adjustments were used at this stage. Genome-wide scan was conducted using common quality control with the following cut offs: 5% for SNPs and samples missingness and <italic>p</italic> = 10<sup>−4</sup> for Hardy-Weinberg disequilibrium. MAF filter was &gt;1%. We combined individual <italic>p</italic>-values across all traits using the Fisher’s combined <italic>p</italic>-value [<xref ref-type="bibr" rid="pgen.1006314.ref063">63</xref>]. The analyses identified a number of promising SNPs with the Fisher’s <italic>p</italic>-value <italic>p</italic><sub><italic>F</italic></sub>&lt;3×10<sup>−9</sup> = 5×10<sup>−8</sup>/15.</p>
<p><bold>Candidate-gene-like analyses</bold> were conducted for the associations of SNPs from a promising pre-selected locus in band 2q22.3 with risks of diseases (see the above section) and death. These analyses were focused on ARIC, FHS, and HRS. The pre-selected SNP rs222826 was directly genotyped in ARIC and FHS. In HRS we used its proxy, rs222827, which was 90 bp away from rs222826. These SNPs were in 100% linkage disequilibrium (LD) in CEU population. These variants were uncommon in Caucasians with MAF of about 2.5% in each of our datasets. We considered a dominant genetic model for the minor allele. <xref ref-type="table" rid="pgen.1006314.t001">Table 1</xref> provides basic characteristics of the selected phenotypes available for the analyses in each study for major allele homozygotes and minor allele carriers.</p>
<p>The data on age at death were available in all studies. The data on onsets of diseases were available in ARIC and FHS. The hazard ratios (HR) of death (all studies) and diseases (FHS and ARIC) were evaluated using the Cox proportional hazards mixed effects regression model (<italic>coxme</italic> package in R) to adjust for potential clustering. Information on both prospective and retrospective onsets of diseases in the FHS was used in these analyses. The use of retrospective onsets in a failure-type model is justified by Prentice and Breslow [<xref ref-type="bibr" rid="pgen.1006314.ref064">64</xref>]. These analyses provide estimates of the effects in a given population. The time variable in the Cox regression analyses was the age at onset of an event or at right censoring. In HRS, we evaluated the odds ratios (ORs) for diseases using a logistic regression model (<italic>glm</italic> function in R). Empirical survival age patterns were characterized by the Kaplan-Meier estimator.</p>
<p><bold>Biomarkers-endophenotypes</bold> for causal mediation analyses were selected based on suggestive and nominally significant (<italic>p</italic>&lt;10<sup>−1</sup>) associations with rs222826/rs222827. These associations were characterized by a linear mixed effects model (<italic>lmer</italic> function in <italic>lme4</italic> package in R). Measurements of BMI, TC, HDL-C, and TG were log-base-10-transformed to offset potential bias due to skewness of their frequency distributions. They were multiplied by 100 for better resolution. Measurements of SBP, and DBP were not transformed as no significant skewness was observed. In the ARIC and FHS datasets, these endophenotypes were measured on multiple occasions during follow-up of the same individuals. We evaluated the associations for SNPs given the measurements of these endophenotypes for individuals of a given age at each examination with available measurements. We used a three-level mixed effects regression model to account for familial and repeated-measurements correlations. Information on longitudinal measurements has multiple advantages including statistical power gain in the analyses [<xref ref-type="bibr" rid="pgen.1006314.ref065">65</xref>]. In the HRS dataset, we used single available assessment of these endophenotypes in 2006–2008.</p>
</sec>
<sec id="sec019">
<title>Adjustments</title>
<p>All statistical tests were adjusted for: (all studies) age, sex; (ARIC) field center; (FHS) FHS cohorts and whether the DNA samples had been subject to whole-genome amplification [<xref ref-type="bibr" rid="pgen.1006314.ref066">66</xref>], and (HRS) HRS cohorts.</p>
</sec>
<sec id="sec020">
<title>Causal mediation analysis</title>
<p>We performed a causal mediation analysis to investigate whether any of the effects of rs222826/rs222827 was mediated by endophenotypes. We examined the role of: (i) selected biomarkers as endophenotypes for diseases and death, and (ii) diseases as endophenotypes for death (see section “<xref ref-type="sec" rid="sec016">Phenotypes</xref>” above). We followed a unified approach proposed by T. Lange et al. [<xref ref-type="bibr" rid="pgen.1006314.ref067">67</xref>] based on marginal structural models (MSMs) [<xref ref-type="bibr" rid="pgen.1006314.ref068">68</xref>] to estimate the direct and indirect effects of these SNPs on the hazards. We assumed that there was no confounding between SNP and outcomes due to Mendelian randomization. We included age and sex as covariates in MSMs and assumed that there was no other unmeasured confounders between the endophenotype and outcome conditioned on age and sex. We adopted linear and logistic regression models for the biomarker and disease endophenotypes, respectively, and the Cox regression model for the outcomes. Robust standard errors were obtained using a bootstrap method with 250 replicates to control for the family structure. One of the limitations of the mediation analysis was that it was still possible that there existed other unmeasured confounders between the mediators and the outcomes, and in this case, the mediation effect was not identifiable.</p>
</sec>
<sec id="sec021">
<title>Meta-analysis</title>
<p>We adopted a fixed effects model with inverse-variance weighting in the meta-analysis. More specifically, the combined effect size was estimated as <inline-formula id="pgen.1006314.e001"><alternatives><graphic id="pgen.1006314.e001g" mimetype="image" orientation="portrait" position="anchor" xlink:href="pgen.1006314.e001.jpg"></graphic><mml:math id="M1"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> and the variance of this effect size was <inline-formula id="pgen.1006314.e002"><alternatives><graphic id="pgen.1006314.e002g" mimetype="image" orientation="portrait" position="anchor" xlink:href="pgen.1006314.e002.jpg"></graphic><mml:math id="M2"><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula>, where <inline-formula id="pgen.1006314.e003"><alternatives><graphic id="pgen.1006314.e003g" mimetype="image" orientation="portrait" position="anchor" xlink:href="pgen.1006314.e003.jpg"></graphic><mml:math id="M3"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> is the effect size in the study <italic>i</italic> and <italic>w<sub>i</sub></italic> is the reciprocal of the variance of <inline-formula id="pgen.1006314.e004"><alternatives><graphic id="pgen.1006314.e004g" mimetype="image" orientation="portrait" position="anchor" xlink:href="pgen.1006314.e004.jpg"></graphic><mml:math id="M4"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>.</p>
</sec>
</sec>
<sec id="sec022">
<title>Accession numbers</title>
<p>This manuscript was prepared using controlled-access data obtained though dbGaP (accession numbers phs000007.v22.p8, phs000280.v2.p1, phs000428.v1.p1). Phenotypic HRS data are available publicly and through restricted access from <ext-link ext-link-type="uri" xlink:href="http://hrsonline.isr.umich.edu/index.php?p=data">http://hrsonline.isr.umich.edu/index.php?p=data</ext-link>.</p>
</sec>
</sec>
<sec id="sec023" sec-type="supplementary-material">
<title>Supporting Information</title>
<supplementary-material content-type="local-data" id="pgen.1006314.s001">
<label>S1 Fig</label>
<caption>
<title>Genomic region in band 2q22.3 harboring rs222826 and rs222827 SNPs located 90 bp apart.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1006314.s002">
<label>S2 Fig</label>
<caption>
<title>Linkage disequilibrium (LD) data (<italic>r</italic><sup><italic>2</italic></sup>) for the variant rs222826 in the 1000GENOMES:phase_3:CEU population.</title>
<p>Red color denotes regulatory regions and those variants in these regions, which are in LD with rs222826. Inserts show characteristics of SNPs from regulatory regions, which are in LD with rs222826.</p>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s002.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1006314.s003">
<label>S1 Table</label>
<caption>
<title>Associations of the minor allele of rs222826<sup>*</sup> SNP with biomarkers in ARIC, FHS cohorts, and HRS.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s003.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1006314.s004">
<label>S2 Table</label>
<caption>
<title>Sources of information for meta-analysis in <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> for columns “With improvements”.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s004.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1006314.s005">
<label>S3 Table</label>
<caption>
<title>Sources of information for meta-analysis in <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> for columns “No improvements”.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s005.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1006314.s006">
<label>S4 Table</label>
<caption>
<title>Numerical estimates of the effect sizes β and standard errors (SE) used for meta-analysis in <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> for columns “With improvements”.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s006.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1006314.s007">
<label>S5 Table</label>
<caption>
<title>Numerical estimates of the effect sizes β and standard errors (SE) used for meta-analysis in <xref ref-type="table" rid="pgen.1006314.t007">Table 7</xref> for columns “No improvements”.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pgen.1006314.s007.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors thank G. Martin for the discussion of the results.</p>
<p>The Framingham Heart Study (FHS) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the FHS and does not necessarily reflect the opinions or views of the FHS, Boston University, or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University.</p>
<p>The Atherosclerosis Risk in Communities Study (ARIC) is carried out as a collaborative study supported by the NHLBI contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. Funding for GENEVA was provided by the National Human Genome Research Institute grant U01HG004402 (E. Boerwinkle).</p>
<p>The Health and Retirement Study (HRS) genetic data is sponsored by the Genetics Resource with HRS April 21, 2010, version G Page 5 of 7 National Institute on Aging (grant numbers U01AG009740, RC2AG036495, and RC4AG039029) and was conducted by the University of Michigan. This manuscript was not prepared in collaboration with HRS investigators and does not necessarily reflect the opinions or views of HRS, or the NHLBI.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pgen.1006314.ref001">
<label>1</label>
<mixed-citation publication-type="book"><name><surname>Robine</surname><given-names>J-M</given-names></name> (<year>2003</year>) <chapter-title>Determining health expectancies</chapter-title>
<publisher-loc>Chichester, West Sussex, England; Hoboken, NJ, USA</publisher-loc>: <publisher-name>Wiley</publisher-name>
<fpage>xiii</fpage>, 428 p. p.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Manton</surname><given-names>KG</given-names></name> (<year>1982</year>) <article-title>Changing concepts of morbidity and mortality in the elderly population</article-title>. <source/>Milbank Mem Fund Q Health Soc
<volume>60</volume>: <fpage>183</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="pmid">6919770</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Fries</surname><given-names>JF</given-names></name> (<year>1980</year>) <article-title>Aging, natural death, and the compression of morbidity</article-title>. <source/>N Engl J Med
<volume>303</volume>: <fpage>130</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198007173030304</pub-id>
<pub-id pub-id-type="pmid">7383070</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref004">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>AL</given-names></name>, <name><surname>Patterson</surname><given-names>NJ</given-names></name>, <name><surname>Plenge</surname><given-names>RM</given-names></name>, <name><surname>Weinblatt</surname><given-names>ME</given-names></name>, <name><surname>Shadick</surname><given-names>NA</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source/>Nat Genet
<volume>38</volume>: <fpage>904</fpage>–<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1038/ng1847</pub-id>
<pub-id pub-id-type="pmid">16862161</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>MacRae</surname><given-names>CA</given-names></name>, <name><surname>Vasan</surname><given-names>RS</given-names></name> (<year>2011</year>) <article-title>Next-generation genome-wide association studies: time to focus on phenotype?</article-title>
<source/>Circ Cardiovasc Genet
<volume>4</volume>: <fpage>334</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.111.960765</pub-id>
<pub-id pub-id-type="pmid">21846867</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Nesse</surname><given-names>RM</given-names></name>, <name><surname>Ganten</surname><given-names>D</given-names></name>, <name><surname>Gregory</surname><given-names>TR</given-names></name>, <name><surname>Omenn</surname><given-names>GS</given-names></name> (<year>2012</year>) <article-title>Evolutionary molecular medicine</article-title>. <source/>J Mol Med (Berl)
<volume>90</volume>: <fpage>509</fpage>–<lpage>522</lpage>.<pub-id pub-id-type="pmid">22544168</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Oeppen</surname><given-names>J</given-names></name>, <name><surname>Vaupel</surname><given-names>JW</given-names></name> (<year>2002</year>) <article-title>Demography. Broken limits to life expectancy</article-title>. <source/>Science
<volume>296</volume>: <fpage>1029</fpage>–<lpage>1031</lpage>. <pub-id pub-id-type="doi">10.1126/science.1069675</pub-id>
<pub-id pub-id-type="pmid">12004104</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Corella</surname><given-names>D</given-names></name>, <name><surname>Ordovas</surname><given-names>JM</given-names></name> (<year>2014</year>) <article-title>Aging and cardiovascular diseases: the role of gene-diet interactions</article-title>. <source/>Ageing Res Rev
<volume>18</volume>: <fpage>53</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2014.08.002</pub-id>
<pub-id pub-id-type="pmid">25159268</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Kulminski</surname><given-names>AM</given-names></name> (<year>2013</year>) <article-title>Unraveling genetic origin of aging-related traits: evolving concepts</article-title>. <source/>Rejuvenation Res
<volume>16</volume>: <fpage>304</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2013.1441</pub-id>
<pub-id pub-id-type="pmid">23768105</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref010">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>Vijg</surname><given-names>J</given-names></name>, <name><surname>Suh</surname><given-names>Y</given-names></name> (<year>2005</year>) <article-title>Genetics of longevity and aging</article-title>. <source/>Annu Rev Med
<volume>56</volume>: <fpage>193</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.med.56.082103.104617</pub-id>
<pub-id pub-id-type="pmid">15660509</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Crespi</surname><given-names>B</given-names></name>, <name><surname>Stead</surname><given-names>P</given-names></name>, <name><surname>Elliot</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia</article-title>. <source/>Proc Natl Acad Sci U S A
<volume>107</volume>
<issue>Suppl 1</issue>: <fpage>1736</fpage>–<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0906080106</pub-id>
<pub-id pub-id-type="pmid">19955444</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>GM</given-names></name> (<year>2012</year>) <article-title>Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies</article-title>. <source/>Mech Ageing Dev
<volume>133</volume>: <fpage>107</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2011.09.001</pub-id>
<pub-id pub-id-type="pmid">21963385</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Benyamin</surname><given-names>B</given-names></name>, <name><surname>McEvoy</surname><given-names>BP</given-names></name>, <name><surname>Gordon</surname><given-names>S</given-names></name>, <name><surname>Henders</surname><given-names>AK</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Common SNPs explain a large proportion of the heritability for human height</article-title>. <source/>Nat Genet
<volume>42</volume>: <fpage>565</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1038/ng.608</pub-id>
<pub-id pub-id-type="pmid">20562875</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Ukraintseva</surname><given-names>S</given-names></name>, <name><surname>Yashin</surname><given-names>A</given-names></name>, <name><surname>Arbeev</surname><given-names>K</given-names></name>, <name><surname>Kulminski</surname><given-names>A</given-names></name>, <name><surname>Akushevich</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants</article-title>. <source/>Biogerontology
<volume>17</volume>: <fpage>109</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-015-9600-1</pub-id>
<pub-id pub-id-type="pmid">26306600</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Yashin</surname><given-names>AI</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Arbeev</surname><given-names>KG</given-names></name>, <name><surname>Arbeeva</surname><given-names>LS</given-names></name>, <name><surname>Akushevich</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Genetic Structures of Population Cohorts Change with Increasing Age: Implications for Genetic Analyses of Human aging and Life Span</article-title>. <source/>Ann Gerontol Geriatr Res
<volume>1</volume>.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Yashin</surname><given-names>AI</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Arbeeva</surname><given-names>LS</given-names></name>, <name><surname>Arbeev</surname><given-names>KG</given-names></name>, <name><surname>Kulminski</surname><given-names>AM</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Genetics of aging, health, and survival: dynamic regulation of human longevity related traits</article-title>. <source/>Front Genet
<volume>6</volume>: <fpage>122</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2015.00122</pub-id>
<pub-id pub-id-type="pmid">25918517</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Day-Williams</surname><given-names>AG</given-names></name>, <name><surname>Zeggini</surname><given-names>E</given-names></name> (<year>2011</year>) <article-title>The effect of next-generation sequencing technology on complex trait research</article-title>. <source/>Eur J Clin Invest
<volume>41</volume>: <fpage>561</fpage>–<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2362.2010.02437.x</pub-id>
<pub-id pub-id-type="pmid">21155765</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Kidambi</surname><given-names>S</given-names></name>, <name><surname>Ghosh</surname><given-names>S</given-names></name>, <name><surname>Kotchen</surname><given-names>JM</given-names></name>, <name><surname>Grim</surname><given-names>CE</given-names></name>, <name><surname>Krishnaswami</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Non-replication study of a genome-wide association study for hypertension and blood pressure in African Americans</article-title>. <source/>BMC Med Genet
<volume>13</volume>: <fpage>27</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-13-27</pub-id>
<pub-id pub-id-type="pmid">22494468</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Barabasi</surname><given-names>AL</given-names></name>, <name><surname>Gulbahce</surname><given-names>N</given-names></name>, <name><surname>Loscalzo</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>Network medicine: a network-based approach to human disease</article-title>. <source/>Nat Rev Genet
<volume>12</volume>: <fpage>56</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2918</pub-id>
<pub-id pub-id-type="pmid">21164525</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>X</given-names></name>, <name><surname>Feng</surname><given-names>T</given-names></name>, <name><surname>Tayo</surname><given-names>BO</given-names></name>, <name><surname>Liang</surname><given-names>J</given-names></name>, <name><surname>Young</surname><given-names>JH</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension</article-title>. <source/>Am J Hum Genet
<volume>96</volume>: <fpage>21</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.11.011</pub-id>
<pub-id pub-id-type="pmid">25500260</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Kaeberlein</surname><given-names>M</given-names></name>, <name><surname>Rabinovitch</surname><given-names>PS</given-names></name>, <name><surname>Martin</surname><given-names>GM</given-names></name> (<year>2015</year>) <article-title>Healthy aging: The ultimate preventative medicine</article-title>. <source/>Science
<volume>350</volume>: <fpage>1191</fpage>–<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad3267</pub-id>
<pub-id pub-id-type="pmid">26785476</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref022">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Guarente</surname><given-names>L</given-names></name> (<year>2011</year>) <article-title>Franklin H. Epstein Lecture: Sirtuins, aging, and medicine</article-title>. <source/>N Engl J Med
<volume>364</volume>: <fpage>2235</fpage>–<lpage>2244</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1100831</pub-id>
<pub-id pub-id-type="pmid">21651395</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Zhavoronkov</surname><given-names>A</given-names></name>, <name><surname>Moskalev</surname><given-names>A</given-names></name> (<year>2016</year>) <article-title>Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives</article-title>. <source/>Frontiers in Genetics
<volume>7</volume>.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Franco</surname><given-names>OH</given-names></name>, <name><surname>Karnik</surname><given-names>K</given-names></name>, <name><surname>Osborne</surname><given-names>G</given-names></name>, <name><surname>Ordovas</surname><given-names>JM</given-names></name>, <name><surname>Catt</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Changing course in ageing research: The healthy ageing phenotype</article-title>. <source/>Maturitas
<volume>63</volume>: <fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.maturitas.2009.02.006</pub-id>
<pub-id pub-id-type="pmid">19282116</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Sierra</surname><given-names>F</given-names></name>, <name><surname>Hadley</surname><given-names>E</given-names></name>, <name><surname>Suzman</surname><given-names>R</given-names></name>, <name><surname>Hodes</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Prospects for Life Span Extension</article-title>. <source/>Annu Rev Med.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref026">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Olshansky</surname><given-names>SJ</given-names></name>, <name><surname>Perry</surname><given-names>D</given-names></name>, <name><surname>Miller</surname><given-names>RA</given-names></name>, <name><surname>Butler</surname><given-names>RN</given-names></name> (<year>2007</year>) <article-title>Pursuing the longevity dividend: scientific goals for an aging world</article-title>. <source/>Ann N Y Acad Sci
<volume>1114</volume>: <fpage>11</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1396.050</pub-id>
<pub-id pub-id-type="pmid">17986572</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref027">
<label>27</label>
<mixed-citation publication-type="book"><name><surname>Fisher</surname><given-names>RA</given-names></name> (<year>1932</year>) <chapter-title>Statistical methods for research workers</chapter-title>
<publisher-loc>Edinburgh</publisher-loc>,: <publisher-name>Oliver and Boyd</publisher-name>
<fpage>xiii</fpage>, 319 p. p.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Kulminski</surname><given-names>AM</given-names></name>, <name><surname>Culminskaya</surname><given-names>I</given-names></name>, <name><surname>Arbeev</surname><given-names>KG</given-names></name>, <name><surname>Arbeeva</surname><given-names>L</given-names></name>, <name><surname>Ukraintseva</surname><given-names>SV</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Birth Cohort, Age, and Sex Strongly Modulate Effects of Lipid Risk Alleles Identified in Genome-Wide Association Studies</article-title>. <source/>PLoS One
<volume>10</volume>: <fpage>e0136319</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0136319</pub-id>
<pub-id pub-id-type="pmid">26295473</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Graff</surname><given-names>M</given-names></name>, <name><surname>Ngwa</surname><given-names>JS</given-names></name>, <name><surname>Workalemahu</surname><given-names>T</given-names></name>, <name><surname>Homuth</surname><given-names>G</given-names></name>, <name><surname>Schipf</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course</article-title>. <source/>Hum Mol Genet
<volume>22</volume>: <fpage>3597</fpage>–<lpage>3607</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt205</pub-id>
<pub-id pub-id-type="pmid">23669352</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Nygaard</surname><given-names>M</given-names></name>, <name><surname>Lindahl-Jacobsen</surname><given-names>R</given-names></name>, <name><surname>Soerensen</surname><given-names>M</given-names></name>, <name><surname>Mengel-From</surname><given-names>J</given-names></name>, <name><surname>Andersen-Ranberg</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Birth cohort differences in the prevalence of longevity-associated variants in APOE and FOXO3A in Danish long-lived individuals</article-title>. <source/>Exp Gerontol
<volume>57</volume>: <fpage>41</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2014.04.018</pub-id>
<pub-id pub-id-type="pmid">24809632</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref031">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>Kulminski</surname><given-names>AM</given-names></name>, <name><surname>Arbeev</surname><given-names>KG</given-names></name>, <name><surname>Culminskaya</surname><given-names>I</given-names></name>, <name><surname>Arbeeva</surname><given-names>L</given-names></name>, <name><surname>Ukraintseva</surname><given-names>SV</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the apolipoprotein e4 allele on lifespan</article-title>. <source/>PLoS Genet
<volume>10</volume>: <fpage>e1004141</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004141</pub-id>
<pub-id pub-id-type="pmid">24497847</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Kulminski</surname><given-names>AM</given-names></name>, <name><surname>Culminskaya</surname><given-names>I</given-names></name>, <name><surname>Arbeev</surname><given-names>KG</given-names></name>, <name><surname>Ukraintseva</surname><given-names>SV</given-names></name>, <name><surname>Stallard</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>The role of lipid-related genes, aging-related processes, and environment in healthspan</article-title>. <source/>Aging Cell
<volume>12</volume>: <fpage>237</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12046</pub-id>
<pub-id pub-id-type="pmid">23320904</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Jarvik</surname><given-names>GP</given-names></name>, <name><surname>Austin</surname><given-names>MA</given-names></name>, <name><surname>Fabsitz</surname><given-names>RR</given-names></name>, <name><surname>Auwerx</surname><given-names>J</given-names></name>, <name><surname>Reed</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>1994</year>) <article-title>Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects</article-title>. <source/>Genet Epidemiol
<volume>11</volume>: <fpage>375</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1002/gepi.1370110407</pub-id>
<pub-id pub-id-type="pmid">7813899</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Atzmon</surname><given-names>G</given-names></name>, <name><surname>Rincon</surname><given-names>M</given-names></name>, <name><surname>Schechter</surname><given-names>CB</given-names></name>, <name><surname>Shuldiner</surname><given-names>AR</given-names></name>, <name><surname>Lipton</surname><given-names>RB</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Lipoprotein genotype and conserved pathway for exceptional longevity in humans</article-title>. <source/>PLoS Biol
<volume>4</volume>: <fpage>e113</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0040113</pub-id>
<pub-id pub-id-type="pmid">16602826</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Yashin</surname><given-names>AI</given-names></name>, <name><surname>De Benedictis</surname><given-names>G</given-names></name>, <name><surname>Vaupel</surname><given-names>JW</given-names></name>, <name><surname>Tan</surname><given-names>Q</given-names></name>, <name><surname>Andreev</surname><given-names>KF</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Genes, demography, and life span: the contribution of demographic data in genetic studies on aging and longevity</article-title>. <source/>Am J Hum Genet
<volume>65</volume>: <fpage>1178</fpage>–<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1086/302572</pub-id>
<pub-id pub-id-type="pmid">10486337</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>CS</given-names></name>, <name><surname>Pencina</surname><given-names>MJ</given-names></name>, <name><surname>Meigs</surname><given-names>JB</given-names></name>, <name><surname>Vasan</surname><given-names>RS</given-names></name>, <name><surname>Levitzky</surname><given-names>YS</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study</article-title>. <source/>Circulation
<volume>113</volume>: <fpage>2914</fpage>–<lpage>2918</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.613828</pub-id>
<pub-id pub-id-type="pmid">16785337</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Dugger</surname><given-names>BN</given-names></name>, <name><surname>Malek-Ahmadi</surname><given-names>M</given-names></name>, <name><surname>Monsell</surname><given-names>SE</given-names></name>, <name><surname>Kukull</surname><given-names>WA</given-names></name>, <name><surname>Woodruff</surname><given-names>BK</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases</article-title>. <source/>Alzheimer Dis Assoc Disord.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Venter</surname><given-names>JC</given-names></name>, <name><surname>Adams</surname><given-names>MD</given-names></name>, <name><surname>Myers</surname><given-names>EW</given-names></name>, <name><surname>Li</surname><given-names>PW</given-names></name>, <name><surname>Mural</surname><given-names>RJ</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>The sequence of the human genome</article-title>. <source/>Science
<volume>291</volume>: <fpage>1304</fpage>–<lpage>1351</lpage>. <pub-id pub-id-type="doi">10.1126/science.1058040</pub-id>
<pub-id pub-id-type="pmid">11181995</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Hillier</surname><given-names>LW</given-names></name>, <name><surname>Graves</surname><given-names>TA</given-names></name>, <name><surname>Fulton</surname><given-names>RS</given-names></name>, <name><surname>Fulton</surname><given-names>LA</given-names></name>, <name><surname>Pepin</surname><given-names>KH</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4</article-title>. <source/>Nature
<volume>434</volume>: <fpage>724</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1038/nature03466</pub-id>
<pub-id pub-id-type="pmid">15815621</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Ovcharenko</surname><given-names>I</given-names></name>, <name><surname>Loots</surname><given-names>GG</given-names></name>, <name><surname>Nobrega</surname><given-names>MA</given-names></name>, <name><surname>Hardison</surname><given-names>RC</given-names></name>, <name><surname>Miller</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Evolution and functional classification of vertebrate gene deserts</article-title>. <source/>Genome Res
<volume>15</volume>: <fpage>137</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1101/gr.3015505</pub-id>
<pub-id pub-id-type="pmid">15590943</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref041">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Clues to function in gene deserts</article-title>. <source/>Trends Biotechnol
<volume>23</volume>: <fpage>269</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2005.04.003</pub-id>
<pub-id pub-id-type="pmid">15922077</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Nobrega</surname><given-names>MA</given-names></name>, <name><surname>Ovcharenko</surname><given-names>I</given-names></name>, <name><surname>Afzal</surname><given-names>V</given-names></name>, <name><surname>Rubin</surname><given-names>EM</given-names></name> (<year>2003</year>) <article-title>Scanning human gene deserts for long-range enhancers</article-title>. <source/>Science
<volume>302</volume>: <fpage>413</fpage>
<pub-id pub-id-type="doi">10.1126/science.1088328</pub-id>
<pub-id pub-id-type="pmid">14563999</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>El-Kasti</surname><given-names>MM</given-names></name>, <name><surname>Wells</surname><given-names>T</given-names></name>, <name><surname>Carter</surname><given-names>DA</given-names></name> (<year>2012</year>) <article-title>A novel long-range enhancer regulates postnatal expression of Zeb2: implications for Mowat-Wilson syndrome phenotypes</article-title>. <source/>Hum Mol Genet
<volume>21</volume>: <fpage>5429</fpage>–<lpage>5442</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds389</pub-id>
<pub-id pub-id-type="pmid">23001561</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Erwin</surname><given-names>GD</given-names></name>, <name><surname>Oksenberg</surname><given-names>N</given-names></name>, <name><surname>Truty</surname><given-names>RM</given-names></name>, <name><surname>Kostka</surname><given-names>D</given-names></name>, <name><surname>Murphy</surname><given-names>KK</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Integrating diverse datasets improves developmental enhancer prediction</article-title>. <source/>PLoS Comput Biol
<volume>10</volume>: <fpage>e1003677</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1003677</pub-id>
<pub-id pub-id-type="pmid">24967590</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref045">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Bravo-Oro</surname><given-names>A</given-names></name>, <name><surname>Lurie</surname><given-names>IW</given-names></name>, <name><surname>Elizondo-Cardenas</surname><given-names>G</given-names></name>, <name><surname>Pena-Zepeda</surname><given-names>C</given-names></name>, <name><surname>Salazar-Martinez</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>A novel interstitial deletion of 2q22.3 q23.3 in a patient with dysmorphic features, epilepsy, aganglionosis, pure red cell aplasia, and skeletal malformations</article-title>. <source/>Am J Med Genet A
<volume>167A</volume>: <fpage>1865</fpage>–<lpage>1871</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36806</pub-id>
<pub-id pub-id-type="pmid">25988649</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref046">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>Xiong</surname><given-names>M</given-names></name>, <name><surname>Jiang</surname><given-names>L</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Qiu</surname><given-names>W</given-names></name>, <name><surname>Fang</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression</article-title>. <source/>Am J Physiol Renal Physiol
<volume>302</volume>: <fpage>F369</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00268.2011</pub-id>
<pub-id pub-id-type="pmid">22012804</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref047">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>SM</given-names></name>, <name><surname>Gaur</surname><given-names>AB</given-names></name>, <name><surname>Lengyel</surname><given-names>E</given-names></name>, <name><surname>Peter</surname><given-names>ME</given-names></name> (<year>2008</year>) <article-title>The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2</article-title>. <source/>Genes Dev
<volume>22</volume>: <fpage>894</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1640608</pub-id>
<pub-id pub-id-type="pmid">18381893</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref048">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>Beltran</surname><given-names>M</given-names></name>, <name><surname>Puig</surname><given-names>I</given-names></name>, <name><surname>Pena</surname><given-names>C</given-names></name>, <name><surname>Garcia</surname><given-names>JM</given-names></name>, <name><surname>Alvarez</surname><given-names>AB</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition</article-title>. <source/>Genes Dev
<volume>22</volume>: <fpage>756</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1101/gad.455708</pub-id>
<pub-id pub-id-type="pmid">18347095</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref049">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Katoh</surname><given-names>M</given-names></name>, <name><surname>Katoh</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB</article-title>. <source/>Int J Oncol
<volume>34</volume>: <fpage>1737</fpage>–<lpage>1742</lpage>. <pub-id pub-id-type="pmid">19424592</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref050">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>A</given-names></name>, <name><surname>Attisano</surname><given-names>L</given-names></name> (<year>2013</year>) <article-title>The TGFbeta superfamily signaling pathway</article-title>. <source/>Wiley Interdiscip Rev Dev Biol
<volume>2</volume>: <fpage>47</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.86</pub-id>
<pub-id pub-id-type="pmid">23799630</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref051">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Wijayarathna</surname><given-names>R</given-names></name>, <name><surname>de Kretser</surname><given-names>DM</given-names></name> (<year>2016</year>) <article-title>Activins in reproductive biology and beyond</article-title>. <source/>Hum Reprod Update.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref052">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>M</given-names></name>, <name><surname>Mowat</surname><given-names>D</given-names></name>, <name><surname>Dastot-Le Moal</surname><given-names>F</given-names></name>, <name><surname>Cacheux</surname><given-names>V</given-names></name>, <name><surname>Kaariainen</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Further delineation of the phenotype associated with heterozygous mutations in ZFHX1B</article-title>. <source/>Am J Med Genet A
<volume>119A</volume>: <fpage>257</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.20053</pub-id>
<pub-id pub-id-type="pmid">12784289</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref053">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Ballarati</surname><given-names>L</given-names></name>, <name><surname>Recalcati</surname><given-names>MP</given-names></name>, <name><surname>Bedeschi</surname><given-names>MF</given-names></name>, <name><surname>Lalatta</surname><given-names>F</given-names></name>, <name><surname>Valtorta</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Cytogenetic, FISH and array-CGH characterization of a complex chromosomal rearrangement carried by a mentally and language impaired patient</article-title>. <source/>Eur J Med Genet
<volume>52</volume>: <fpage>218</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2009.02.004</pub-id>
<pub-id pub-id-type="pmid">19236961</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref054">
<label>54</label>
<mixed-citation publication-type="book"><name><surname>Taylor</surname><given-names>J</given-names></name> (<year>2001</year>) <source/>Evolution of Gene Deserts in the Human Genome. <publisher-loc>eLS</publisher-loc>: <publisher-name>John Wiley &amp; Sons, Ltd.</publisher-name></mixed-citation>
</ref>
<ref id="pgen.1006314.ref055">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Sharrett</surname><given-names>AR</given-names></name> (<year>1992</year>) <article-title>The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component</article-title>. <source/>Ann Epidemiol
<volume>2</volume>: <fpage>467</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="pmid">1342297</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref056">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Govindaraju</surname><given-names>DR</given-names></name>, <name><surname>Cupples</surname><given-names>LA</given-names></name>, <name><surname>Kannel</surname><given-names>WB</given-names></name>, <name><surname>O'Donnell</surname><given-names>CJ</given-names></name>, <name><surname>Atwood</surname><given-names>LD</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Genetics of the Framingham Heart Study population</article-title>. <source/>Adv Genet
<volume>62</volume>: <fpage>33</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-2660(08)00602-0</pub-id>
<pub-id pub-id-type="pmid">19010253</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref057">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>Splansky</surname><given-names>GL</given-names></name>, <name><surname>Corey</surname><given-names>D</given-names></name>, <name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Atwood</surname><given-names>LD</given-names></name>, <name><surname>Cupples</surname><given-names>LA</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination</article-title>. <source/>Am J Epidemiol
<volume>165</volume>: <fpage>1328</fpage>–<lpage>1335</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwm021</pub-id>
<pub-id pub-id-type="pmid">17372189</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref058">
<label>58</label>
<mixed-citation publication-type="journal"><name><surname>Cupples</surname><given-names>LA</given-names></name>, <name><surname>Heard-Costa</surname><given-names>N</given-names></name>, <name><surname>Lee</surname><given-names>M</given-names></name>, <name><surname>Atwood</surname><given-names>LD</given-names></name> (<year>2009</year>) <article-title>Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data</article-title>. <source/>BMC Proc
<volume>3</volume>
<issue>Suppl 7</issue>: <fpage>S3</fpage>
<pub-id pub-id-type="pmid">20018020</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref059">
<label>59</label>
<mixed-citation publication-type="journal"><name><surname>Lahoz</surname><given-names>C</given-names></name>, <name><surname>Schaefer</surname><given-names>EJ</given-names></name>, <name><surname>Cupples</surname><given-names>LA</given-names></name>, <name><surname>Wilson</surname><given-names>PW</given-names></name>, <name><surname>Levy</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study</article-title>. <source/>Atherosclerosis
<volume>154</volume>: <fpage>529</fpage>–<lpage>537</lpage>. <pub-id pub-id-type="pmid">11257253</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref060">
<label>60</label>
<mixed-citation publication-type="journal"><name><surname>Myers</surname><given-names>RH</given-names></name>, <name><surname>Schaefer</surname><given-names>EJ</given-names></name>, <name><surname>Wilson</surname><given-names>PW</given-names></name>, <name><surname>D'Agostino</surname><given-names>R</given-names></name>, <name><surname>Ordovas</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study</article-title>. <source/>Neurology
<volume>46</volume>: <fpage>673</fpage>–<lpage>677</lpage>. <pub-id pub-id-type="pmid">8618665</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref061">
<label>61</label>
<mixed-citation publication-type="journal"><name><surname>Juster</surname><given-names>FT</given-names></name>, <name><surname>Suzman</surname><given-names>R</given-names></name> (<year>1995</year>) <article-title>An overview of the health and retirement study</article-title>. <source/>Journal of Human Resources
<volume>30</volume>: <fpage>S7</fpage>–<lpage>S56</lpage>.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref062">
<label>62</label>
<mixed-citation publication-type="journal"><name><surname>Purcell</surname><given-names>S</given-names></name>, <name><surname>Neale</surname><given-names>B</given-names></name>, <name><surname>Todd-Brown</surname><given-names>K</given-names></name>, <name><surname>Thomas</surname><given-names>L</given-names></name>, <name><surname>Ferreira</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source/>Am J Hum Genet
<volume>81</volume>: <fpage>559</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref063">
<label>63</label>
<mixed-citation publication-type="book"><name><surname>Fisher</surname><given-names>RAS</given-names></name> (<year>1970</year>) <chapter-title>Statistical methods for research workers</chapter-title>
<publisher-loc>Edinburgh</publisher-loc>: <publisher-name>Oliver and Boyd</publisher-name>.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref064">
<label>64</label>
<mixed-citation publication-type="journal"><name><surname>Prentice</surname><given-names>R</given-names></name>, <name><surname>Breslow</surname><given-names>N</given-names></name> (<year>1978</year>) <article-title>Retrospective studies and failure time models</article-title>. <source/>Biometrika
<volume>65</volume>: <fpage>153</fpage>–<lpage>158</lpage>.</mixed-citation>
</ref>
<ref id="pgen.1006314.ref065">
<label>65</label>
<mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>G</given-names></name>, <name><surname>Rice</surname><given-names>TK</given-names></name>, <name><surname>Gu</surname><given-names>CC</given-names></name>, <name><surname>Rao</surname><given-names>DC</given-names></name> (<year>2009</year>) <article-title>Application of three-level linear mixed-effects model incorporating gene-age interactions for association analysis of longitudinal family data</article-title>. <source/>BMC Proc
<volume>3</volume>
<issue>Suppl 7</issue>: <fpage>S89</fpage>
<pub-id pub-id-type="pmid">20018085</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref066">
<label>66</label>
<mixed-citation publication-type="journal"><name><surname>Ikram</surname><given-names>MA</given-names></name>, <name><surname>Seshadri</surname><given-names>S</given-names></name>, <name><surname>Bis</surname><given-names>JC</given-names></name>, <name><surname>Fornage</surname><given-names>M</given-names></name>, <name><surname>DeStefano</surname><given-names>AL</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Genomewide association studies of stroke</article-title>. <source/>N Engl J Med
<volume>360</volume>: <fpage>1718</fpage>–<lpage>1728</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0900094</pub-id>
<pub-id pub-id-type="pmid">19369658</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref067">
<label>67</label>
<mixed-citation publication-type="journal"><name><surname>Lange</surname><given-names>T</given-names></name>, <name><surname>Vansteelandt</surname><given-names>S</given-names></name>, <name><surname>Bekaert</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>A simple unified approach for estimating natural direct and indirect effects</article-title>. <source/>Am J Epidemiol
<volume>176</volume>: <fpage>190</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwr525</pub-id>
<pub-id pub-id-type="pmid">22781427</pub-id></mixed-citation>
</ref>
<ref id="pgen.1006314.ref068">
<label>68</label>
<mixed-citation publication-type="journal"><name><surname>Robins</surname><given-names>JM</given-names></name>, <name><surname>Hernan</surname><given-names>MA</given-names></name>, <name><surname>Brumback</surname><given-names>B</given-names></name> (<year>2000</year>) <article-title>Marginal structural models and causal inference in epidemiology</article-title>. <source/>Epidemiology
<volume>11</volume>: <fpage>550</fpage>–<lpage>560</lpage>. <pub-id pub-id-type="pmid">10955408</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>